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For decades, the historical division between the biomedical
community and the scholars of social structure about how the
final phenotype is shaped seemed irreducible. It produced par-
ticularly heated arguments within the discipline of gender-
specific medicine. Clinical investigators insisted that the
answers to what shaped function lay almost entirely within our
biological sex while anthropologists, sociologists, and even
epidemiologists maintained that biomedical investigators were
ignoring the powerful impact of the environment on shaping
the phenotype, that is, that “maleness” and “femaleness” are
profoundly influenced by the environment. The only thing
about which both camps agreed was that to separate the indi-
vidual impact of the two—biology and environment—was an
impossible task. It was the Gordian knot of gender-specific
medical studies: Before the genomic era, lecture after lecture
in conferences like these began with the effort to describe the
distinction between ”sex” and ”gender.” With the discovery of
the structure of the human genome less than 2 decades ago, a
unifying hypothesis began to emerge. The first piece of data
was that the human genome was 99.5% identical in all humans
and that the actual number of individual genes was much
smaller than had been predicted: 20 000 to 25 000 (Human
Genome Project) and at a maximum, 46 000 (Stephen Salz-
berg). How did this explain the enormous variability- and
adaptability-of humans both within and across generations? If
biological sex is significantly restrictive for the phenotype,
how do we explain memory, learning new skills, and adjust-
ment to the world around us? The answer lies in how genes are
expressed: their function is modified by actual chemical tags
attached to the various components of the genome. These mod-
ifications do not change underlying structure, but profoundly
modify the way genes are up or down regulated, modify
mRNA, and even postranslationally modify protein structure
through folding, stabilization, and binding partners. The results
are the precisely engineered components of the individual
human. Importantly, some of the epigenetic changes in the gen-
ome can be inherited by future generations in a sex-specific way.
In short, the science of epigenetics knits the once separate find-
ings of social scientists and biomedical investigators into a uni-
fied functional whole. We might well consider substituting
epigenetic medicine for the term gender-specific medicine, a
term that tells a more accurate and complete story and unites
the 2 concepts that are no longer separable: sex and gender.
Prioritising Sex and Gender Equity in Health
in Europe
Peggy A. Maguire1
1European Institute of Women’s Health, Dublin, Ireland
The European Union can do more to prioritize women’s health
in order to improve the health of all, targeting existing gaps and
challenges. Action must be taken early and at critical points to
ensure health and well-being from preconception to childhood
through to old age. Biological and social influences are critical
to health. Women face higher rates of diseases, such as in
breast cancer, osteoporosis, and autoimmune diseases than do
men. Other diseases affect men and women differently, includ-
ing diabetes, depression, and cardiovascular disease. Women
do not present the same for conditions and respond differently
to treatment than do men. Strategies must account for these
differences. Many factors outside of the health sector—such
as socioeconomic status, education, culture, and ethnicity—
affect behavior and resource access. Sex and gender have
important implications for health-care delivery. Due to
women’s reproductive role, their health affects the health of
their unborn child and that of future generations. Health care
and health systems should be highly responsive to women, but
too often fail them. Translating the evidence from sex and
gender research into regulatory practice leads to more targeted,
safe, and effective opportunities for health and health care.
Women are the heaviest medicine users, yet they are under-
represented in research and data. Consequently, the evidence
base is weak for women as well as for older people. The Clin-
ical Trials Regulation must be implemented in order to combat
the underrepresentation of women in clinical trials. Health-care
systems must be supported to systematically and more
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effectively overcome sex and gender inequities. Treatments
must be delivered, responding to differences, such as sex, gen-
der, and age, and adapt treatment to ensure that all people and
patients in Europe receive the best available care.
Focusing on Women’s Health: Policies That
Work? Experiences From an Austrian
Initiative
Beate Wimmer-Puchinger, PhD1, and Sylvia Gaiswinkler,
MSc2
1Austrian Association of Psychologists, Vienna, Austria
2Gesundheit Österreich GesmbH, Vienna, Austria
After the highly successful Vienna Women’s Health Program
adopted in 1999 by the city parliament as a regional model of
good practice, the Austrian Ministry of Women’s Affairs and the
Austrian Ministry of Health decided 2014/2015 to develop an
Action Plan for Women’s Health on the national level. Goals of
the Action Plan mirror the different stages of life: girls and
young women, working women, and elderly and old women.
Austrian Women’s Health Action Plan was elaborated by
interdisciplinary highly professional expert working groups.
The Plan highlights and addresses critical issues of women’s
health based on a biopsychosocial view. Following this
approach, the goals focus not only on women’s health but
furthermore on the social determinants of health such as pov-
erty, equal pay, and gender roles. The Action Plan was adopted
by the Austrian parliament and consists of 17 goals and pro-
poses 40 measures on achieving these goals. To ensure the
implementation and progress, the departments for health and
the departments of women’s affairs of all 9 counties were acti-
vated and as “Focal Points” established. These act as coordi-
nating body within the 9 countries. The overall aim of the
“Focal Points” is that all over Austria, in the cities as well as
countryside, women’s health issues are known, understood, and
services for special issues like violence, body images, sexual
health, reproductive health, and gender-specific chronic dis-
eases are offered. To advance the process of the implementa-
tion, the focal points are establishing regional networks,
3 times a year Focal Point meetings are held to exchange
experiences as well as an Austrian “Women’s Health Dia-
logue” conferences for a broader audience. Summarizing these
joint efforts, awareness for women’s health has increased pol-
icies as well as in experts and the population. Therefore, it
seems to be a model of good practice because it works.
Chronotype, Gender, and Health
Roberto Manfredini1
1Faculty of Medicine, Pharmacy and Prevention, University of
Ferrara, Ferrara, Italy
The circadian preference (chronotype) reflects the individual’s
internal circadian rhythm that influences the sleep-activity
cycle in a 24-hour period. It can be self-assessed by the
Morningness-Eveningness Questionnaire (MEQ), identifying
Morning-types, Evening-types, and neither-types or Intermedi-
ate. Many genes participate in the determination of chronotype,
and PERIOD2, a core molecular component of the circadian
clock, seems to play active role. However, individual chronotype
is not immutable, and varies with age and sex. Eveningness is
more frequent in younger subjects, whereas morningness is
greater in the advancing age. Men are typically later chronotypes
than women before 40, but earlier types after 40. Moreover,
environmental cues, for example light in particular, may play
an important role. For billion years, the light/dark cycle deter-
mined by the sun has regulated the endogenous circadian rhyth-
micity in almost all life forms. From the XIXth century, the
availability of incandescent light sources (ILSs), allowed
humans to work over the 24-hour of a day, leading to a “shift-
work desynchronization.” Due to many advantages, that is, low
energy consume and smaller size screen, light-emitting diodes
(LEDs) have replaced ILS, becoming the dominant source for
urban lighting and personal domestic devices, that is smart-
phones, tablets, so on However, the LED-emitted blue light
elicits a significant, dose-dependent, suppression of endogenous
melatonin, with negative consequences on sleep. Light-at-night
(LAN) has an impact on chronotype and health. A growing body
of evidence indicates an association between eveningness and
health problems, including (i) unhealthy habits and diet, more
smoking, and alcohol drinking; obesity, metabolic syndrome,
diabetes; (ii) psychological and psychological disorders,
impulsivity, anger, depression, and anxiety (especially in
women), risk taking behavior, psychopathology and person-
ality traits, and (iii) sleep disorders, later bedtime and wake-up
time, irregular sleep-wake schedule, subjective poor sleep, exces-
sive daytime sleepiness and poor sleep quality (especially in
women). These findings open new perspectives for prevention.
The Biological Clock and Sleep
Eva S. Schernhammer, MD, DrPH1
1Department of Epidemiology, Center for Public Health, Medical
University of Vienna, Vienna, Austria
Virtually all cells follow the 24-hour circadian rhythm of a
hypothalamic master pacemaker that evolved in the natural
light–dark cycle. Decoding this biologic clock, which is the
prime regulator of sleep/wake, culminated in the Nobel Prize
in Physiology or Medicine 2017 for the discovery of molecular
mechanisms controlling the circadian rhythm. It is now recog-
nized that a strong, unperturbed biologic clock is a hallmark of
healthy aging. The introduction of electric light, however, pre-
sents unique challenges: Increases in the risk of major chronic
disease and mortality have been associated with night work.
Further, the ubiquity of light at night implicates potential risk
not only for night workers but for everyone. Triggered by the
melatonin hypothesis posed by Richard Stevens und Scott
Davis in 1986, substantial effort has been put toward decipher-
ing these negative health effects. In 2007, based on convincing
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evidence from animal research, yet only a limited number of
observational studies, the World Health Organization (WHO)
classified nightshift work as a class 2A carcinogen (“probably
carcinogenic”). A large body of additional evidence has now
accumulated, giving rise to a WHO reassessment of the carci-
nogenicity of night shift work in June 2019. In this presenta-
tion, an overview and current status of the accumulated
epidemiological evidence is provided, and future directions are
discussed.
Biological Clock and Sleep
Riva Tauman1
1Sleep Disorders Center, Tel Aviv Souraski Medical Center, Sackler
School of Medicine, Tel Aviv University, Israel
Sleep is important to our health and well-being and is essential
to our homeostasis. The regulation of the sleep-wake cycle is
governed by the circadian system. The circadian system acts as
a “supra-physiological” system that coordinates and regulates
many physiological functions on a 24-hour basis including core
body temperature, hormone secretion, appetite, and the sleep-
wake cycles. Proper organization of circadian rhythms is a key
for normal function and disruption to the circadian rhythm
leads to adverse consequences. The human circadian system
actively synchronizes (entrains) to the 24-hours day via envi-
ronmental signals (light and darkness). However, the entrain-
ment of the circadian system to the 24-hour cycles is not
constant. Differences between individuals in this phase of
entrainment is shaped by genotype, environment, gender, and
age leading to different phenotypes, known as chronotypes.
There are several circadian sleep disorders including: shit work
disorder, the relative new disorder called “social jet-lag,”
delayed sleep phase syndrome, advanced sleep phase syn-
drome, irregular sleep-wake rhythm, and non-24-hour sleep-
wake rhythm. An overview on these sleep disorders will be
provided.
Why so Slow? Content and Context in
Gender Medicine
Sabine Oertelt-Prigione1,2, Sarah Hiltner1, Sabine
Jenner3, and Jenny Jesuthasan2
1Primary Care Department, Radboud Institute of Health Sciences,
Radboudumc, Nijmegen, the Netherlands
2Institute of Legal Medicine, Charité-Universitätsmedizin, Berlin,
Germany
3Equal Opportunities Office, Charité-Universitätsmedizin, Berlin,
Germany
Although the political and institutional support for sex and
gender-sensitive medicine has significantly increased over the
last decade, the implementation of its concepts into practice is
lagging behind. General knowledge and single best practice
examples are available, yet they are not widely adopted. Sex
and gender-medicine is an innovative approach to medical
research, care, and teaching. Its implementation is a complex
change process that questions the underpinnings of traditional
androcentric medicine. Given the complexity of the process, its
implementation can only be achieved through a systemic
approach and the sole production of sex-specific knowledge
will not lead to innovation. In this talk, I will briefly discuss
3 examples from the (a) academic, (b) organizational, and (c)
societal context to demonstrate how content and context are
interlinked. Starting with (a) a focus on sex and gender-
sensitive medicine in Europe, I will highlight how the align-
ment of content, institutional, and sociopolitical context is
needed to achieve implementation. I will then proceed to (b)
the role of context in the establishment of organizational guide-
lines against gender discrimination and sexual harassment.
Here again, perceived need, pressure groups, and institutional
support are essential in mandating lasting institutional change.
Last, I will point out (c) the role of context in the development
of innovative health-care concepts for vulnerable populations.
A detailed need analysis, stakeholder networks, and structural
support are mandatory for the implementation of successful
social innovations. All 3 examples demonstrate how the pres-
ence of innovative content and best practices alone does not
suffice to achieve change. Only the alignment of knowledge,
perceived need, and political will lead to rapid and effective
implementation. Most intriguingly, however, the examples
demonstrate that context can be shaped to favor adoption of
innovation. These learnings could provide a blueprint to accel-
erate the implementation of sex and gender-sensitive medicine.
Reducing the Gender Gap in Medical
Academic Activities in Japan
Miyuki Katai1
1Department of General and Women’s Medicine, Tokyo Women’s
Medical University, Shinjuku-ku, Tokyo, Japan
According to the latest data released by the Japanese govern-
ment, the percentage of women medical doctors (MDs) in
Japan is 21.1%, which is the lowest among the Organization
for Economic Co-operation and Development countries as of
2013. However, in 2016, the ratio of women MDs in their 20s
reached 34.6% in Japan, which was the highest among all age
groups. As with other occupations, the employment rate of
Japanese women MDs shows an “M-shaped curve” due to the
decrease in the rate that reflects maternity and childcare leave.
According to a survey by the Ministry of Health, Labour and
Welfare, the employment rate among women decreases to its
lowest point (73%) at the 11th year after licensure (estimated
age: 37 years), compared with 89.9% among men in the same
age cohort. Although the employment rate increases to over
80% among women in their 50s, it remains lower than that
among men of the same age. One way to address this issue is
by promoting changes in health policies, the working environ-
ment, and established notions about women and childcare.
Since around 2006, federal funding in the form of grants and
incentives from the Ministry of Education, Culture, Sports,
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Science and Technology and the Ministry of Health, Labour
and Welfare has been allocated for activities that promote the
career development of women MDs and prevent job abandon-
ment. Furthermore, universities, academic societies, prefec-
tural governments, and the Japan Medical Association and
affiliated associations have been working to address these
issues. We analyzed female participation in the Japanese Soci-
eties of Internal Medicine and Subspecialties. Especially, we
conducted a detailed analysis of the Japan Endocrine Society. I
would like to introduce the results of this analysis and our
efforts to reduce the gender gap in academic activities over the
past 10 years.
The 9th Congress of the International Society
for Gender Medicine (2019) Sex and Gender
in Cardiovascular Medicine
Hiroaki Shimokawa, MD, PhD1
1Department of Cardiovascular Medicine, Tohoku University
Graduate School of Medicine, Sendai, Japan
The importance of sex and gender differences has been emer-
ging in all medical fields, including cardiovascular medicine.
In our department, we have been conducting research for sex
difference, ranging from basic to clinical and epidemiology
research. We have demonstrated the importance of sex differ-
ences in ischemic heart disease, heart failure, pulmonary hyper-
tension, arrhythmias, and even disaster medicine. In ischemic
heart disease, we demonstrated that Rho-kinase, a molecular
switch for vascular smooth muscle contraction, plays a central
role not only in vasospastic angina but also in microvascular
angina. The long-term prognosis of patients with vasospastic
angina is deteriorated when coronary microvascular dysfunc-
tion is coexisted, both of which are mediated by Rho-kinase
activation. Importantly, the expression of Rho-kinase is mark-
edly suppressed by estrogen and enhanced by nicotine. Indeed,
smoking is the strongest risk factor in postmenopausal women.
In heart failure, we demonstrated the sex differences in terms of
clinical characteristics, transition to symptomatic heart failure,
and long-term prognosis. In pulmonary hypertension, it is
widely known that the prevalence of the disorder is higher in
females than in males, while the long-term prognosis is better
in females than in males. We found that sex hormones may be
differently involved in the development of pulmonary hyper-
tension and right ventricular dysfunction. In arrhythmias, sex
differences are also involved, especially in atrial fibrillation
and Brugada syndrome. Finally, in 2011, we experienced the
Great East Japan Disaster, where the City of Sendai was the
center of the disaster. We found that although all types of
cardiovascular diseases and pneumonia were increased in both
sexes after the earthquake, post-traumatic stress disorder was
associated with increased cardiovascular diseases, especially in
female patients, after the earthquake. Thus, sex and gender
differences are one of the most important points and therapeu-
tic targets in cardiovascular medicine.
Sex and Gender in Arterial Vascular Stiffness—
A Modern Management in Risk Assessment
Ute Seland1,2
1Gender in Medicine (GiM), Charité-Universitaetsmedizin Berlin,
Germany
2DZHK (German Centre for Cardiovascular Research), partner site,
Berlin, Germany
Arterial stiffness is an important component of vascular ageing
and a potent cardiovascular disease (CVD) risk predictor. The
concept that “early vascular aging” (EVA) is better related to the
prognosis of CVE compared to chronological age is rapidly evol-
ving. Methods for assessing vascular ageing, for example, non-
invasive measurement of pulse wave velocity (PWV) and
augmentation index (AIx), are not yet established in clinical rou-
tine practice. Clinical data of 2 main studies will be presented by
the author to elucidate the benefit of arterial vascular stiffness
measurement for clinical practice both for general practitioners
and gynaecologists: The “Berlin Risk Evaluation in Women”
study was performed to measure the vascular health of women
living in Berlin. The study tested the hypothesis that the measure-
ment of AIx and PWV is useful in addition to that of traditional
cardiovascular risk factors when assessing the risk of left ventri-
cular diastolic dysfunction (LVDD). The study data show that the
measurement of pathological aortic PWV values  9.7 m/s pre-
dict the risk of LVDD, in addition to the cardiovascular risk
factors postmenopausal age and waist circumference > 80 cm.
The high prevalence of vascular dysfunction and arterial stiffness
(45%) in this female cohort and the high prevalence of LVDD
(31.7%) should encourage implementation of aortic PWV mea-
surement to improve cardiovascular-risk assessment. The aim of
the sub study of BASE-II was to examine age and sex differences
of arterial wave reflection and to estimate associations with endo-
genous (estradiol)- and exogenous (oral contraceptives [OCP]
and postmenopausal hormone therapy [HRT]) sex hormones.
Pulse wave velocity and AIx were measured in 590 male and
400 female participants, recruited from 2 age-strata, 22 to 35 years
and 60 to 82 years. The findings suggest important sex differences
in measures of arterial wave reflection, with a higher mean AIx
observed in women compared to men. Oral contraceptives pro-
mote the development of hypertension, maybe by increasing the
AIx. Suppressed endogenous estradiol levels could be responsible
for this increased arterial wave reflection, due to higher vasotonus
of the small and medium arteries compared to the non-OCP users.
Among postmenopausal women, no associations of HRT with
estradiol level and measures of arterial stiffness were observed.
Sex Differences in Immunity and Immune-
Mediated Diseases
Elena Ortona1, Maria Luisa Dupuis1, Maria Cristina
Gagliardi1, Maria Teresa Pagano1, Katia Fecchi1, and
Marina Pierdominici1
4 Gender and the Genome
1Center for Gender Specific Medicine, Istituto Superiore di Sanità,
Viale Regina Elena, Rome, Italy
Immune response differs between women and men at many
levels. In general, females mount stronger innate and adaptive
immune responses in comparison to males. In particular,
women show more effective phagocytosis and antigen presen-
tation, stronger production of inflammatory cytokines, higher
absolute number of CD4þ T lymphocytes, higher levels of
circulating antibodies, in comparison to men. Genetic, epige-
netic, hormonal, and environmental factors contribute to sex
differences in immune response. The strong immune response
in women, on one hand, appears to be beneficial, leading to the
reduction of pathogen load and accelerating pathogen clear-
ance, but, on the other hand, it can be detrimental by causing
autoimmune or inflammatory diseases. Accordingly, most
autoimmune diseases (eg, rheumatoid arthritis, Sjögren syn-
drome, primary biliary cirrhosis, antiphospholipid syndrome,
systemic sclerosis, multiple sclerosis, and systemic lupus
erythematosus) are more prevalent in women than in men and
symptoms, disease course, and response to therapy may also
differ between males and females. The search for the mechan-
isms responsible for these differences could lead to the identi-
fication of sex-specific diagnostic, prognostic and predictive
biomarkers, and to the identification of new therapeutic targets.
Our studies focused on estrogen (ER) and vitamin D (VDR)
receptors in T cells of men and women. We found that ERb
expression could be considered a marker of disease progression
and represents a potential therapeutic target in systemic auto-
immune diseases such as systemic lupus erythematosus and
rheumatoid arthritis. We also observed that VDR expression
is significantly different in T lymphocytes from women and
men and its activation significantly inhibited IL-17 and TNF-a
production. In conclusion, ER and VDR could represent impor-
tant biomarkers and therapeutic target in autoimmune diseases
opening new perspective in the application of a gender-
specific, personalized treatment.
Sex Differences in Invisible Illnesses: Chronic
Pain, Fibromyalgia, and Hypermobility
Disorders
Katelyn A. Bruno, PhD1, Andrea C. Morales, MD1, Rinald
Paloka1, John M. Sousou1, Jenil B. Patel, MD1, Shelby T.
Watford1, Anna A. Mease, MPH1, Nicholas A. Courson2,
Peter T. Dorsher, MD3, Todd D. Rozen, MD4, Edsel B.
Bittencourt, PT2, Lynsey A. Seim, MD5, and DeLisa
Fairweather, PhD1
1Department of Cardiovascular Medicine, Mayo Clinic, FL, USA
2Department of Rehabilitation, Mayo Clinic, FL, USA
3Department of Physical Medicine and Rehabilitation, Mayo Clinic,
FL, USA
4Department of Neurology, Mayo Clinic, FL, USA
5Department of General Internal Medicine, Mayo Clinic, FL, USA
Recent research suggests that chronic pain conditions like
hypermobile spectrum disorder (HSD) and hypermobile Ehlers
Danlos syndrome (hEDS), which are considered invisible ill-
nesses, occur fairly often in the population; 255 million or 3.5%
people affected worldwide. Based on Mendelian genetics, the
sex ratio of hEDS patients is expected to be 1:1, but in fact the
disease affects females more than males. Fibromyalgia is an
illness associated with chronic pain and estimated to occur in
2% of the population (9:1, W: M). In spite of the large number
of patients with these conditions, the pathogenesis of disease
remains largely unknown. We performed a retrospective study
examining sex and age difference, presence of comorbidities,
vitals and labs in around 8000 patients from the Mayo Clinic
EMR who were diagnosed with one of these chronic pain con-
dition. We found that HSD, hEDS, and fibromyalgia occur
more often in women with hEDS occurring more often in pre-
menopausal women and fibromyalgia occurring more often in
postmenopausal women. Comorbidities that were examined
include fatigue, migraine, IBS, chronic pain, and depression.
We also found that sex differences occur in common comor-
bidities such as migraines. We found that females with fibro-
myalgia had more migraines and depression compared to
males, whereas males had more fatigue. When we examined
comorbidities according to age using age 50 as a surrogate for
menopause status, we found that women under 50 were more
likely to have migraines while women over 50 were more likely
to have hypertension. Knowing common comorbidities and/or
vital/lab trends affecting patients could lead to a better under-
standing of the pathogenesis of disease and lead to better treat-
ment strategies for patients. Our findings highlight the
importance of studying sex and age differences in disease and
provide insight on factors that may contribute to chronic pain in
patients with these conditions.
Blood Sera of Women Affected by
Fibromyalgia: An NMR Metabolomics
Analysis
Manuela Grimaldi1, Michela Buonocore1, Carmen
Ricciardelli2, Arianna Pallavicini2, Paola Sabatini3, Patrizia
Amato2, and Anna Maria D’Ursi1
1Department of Pharmacy, University of Salerno, Fisciano, Salerno,
Italy
2SerT ASL Salerno Cava dei Tirreni, Italy
3U.O.C Clinical Pathology D.E.A. III Umberto I, Nocera Inferiore,
Salerno, Italy
Fibromyalgia syndrome (FMS) is a female prevalent chronic
pain disease. Timely diagnosis and accurate monitoring are
decisive to improve the accuracy of therapy. In the present
work, we present an NMR-based metabolomic study of blood
sera of FMS patients. Spectral analyses of samples were con-
ducted using a 600 MHz 1H nuclear magnetic resonance
(NMR) spectrometer; data processing and analyses were per-
formed using Bayesil and MetaboAnalyst software.
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Unsupervised and supervised multivariate analyses distin-
guished control and FMS patient groups. Sample of patients
analyzed versus control according to age and gender led to the
identification of a characteristic metabolomic profile that can
be a useful tool to classify FMS affected women. Nuclear
magnetic resonance based metabolomic analysis confirms to
be a suitable tool to explore the metabolite information in order
to improve existing medical practice and planning personalized
therapies.
Gender and Pain: Theoretical Foundations
and Practical Applications
Kateryna Ostrovska1
1The Ukrainian Society for Gender and Anti-Aging Medicine, Dnipro,
Ukraine
The gender differences in experience of pain became a burning
issue in current years. Women are corroborated to be at a higher
risk of chronic pain compared to men and even suffer from
more severe aches. Gender divergences in pain perception are
hypothesized to be based on the modifying impact of gonadal
hormones on the neural substrate. The existing evidence on the
distribution of sex hormones and their receptors in the areas of
the central and peripheral nervous system engaged with the
nociceptive transmission revealed causal pathways. The pecu-
liarities of both personalities: a health-care worker and a patient
evidently contribute to gender bias in pain therapy. Various
biological, psychological, and social factors (genetics, endo-
genous opioid system, sex hormones, gender roles, pain reliev-
ing models, and catastrophizing) are involved as well.
Furthermore, the gender discrepancies in responses to the med-
icamental and nonmedicamental pain treatment are discovered,
whereas the findings may fluctuate in relation to the definite
methods of treatment and characteristics of pain. As far as
prescribed doses of remedies are calculated on a model of 70
kg weighing man, female patients may be posed at risk of either
enlarged therapeutic or adverse effects of the drug. The predis-
positions are explained by lower mean body weight paralleling
a higher average percentage of body fat that leads to elevated
average drug concentrations in women in comparison with
male patients. The pain management cannot be adjusted in
accordance with gender specificity nowadays. Hence, further
researches clarifying the mechanisms defining gender differ-
ences in pain responses for the purpose of personalized therapy
are warranted.
Clinical Feature of Coronary Artery Disease
in Japan
Hiroaki Kawano, MD PhD1
1Deptartment Cardiovascular Medicine, Kumamoto University,
Kumamoto, Japan
The incidence of angina pectoris in women increases after 60
years of age in Japan as other western countries. Coronary
spasm has been reported to play an important role in the patho-
genesis of ischemic heart disease in general, including acute
coronary syndrome. Approximately 40% of angina pectoris is
related to coronary spasm in Japan. Impairment of endothelial
function as well as the hypercontractile response of smooth
muscle in coronary artery may play an important role the gen-
esis of coronary spasm. A hyperventilation test is a specific test
for coronary spastic angina (CSA). Estrogen replacement pre-
vents the hyperventilation-induced attacks in postmenopausal
women with CSA. Thus, estrogen may prevent coronary
spasm. Even though a lot of perimenopausal women have chest
symptoms in Japan, most of those patients do not go to hospital,
or do not receive any treatment due to be diagnosed as cardi-
oneurosis or unknown. These facts are not good for women’s
health. Internists must be aware of this lapse and need to induce
these women that estrogens may be efficacious and effective.
Sex Differences in the Management of Heart
Failure
Kotaro Nochioka1, Yasuhiko Sakata1, and Hiroaki
Shimokawa1
1Department of Cardiovascular Medicine, Tohoku University
Graduate School of Medicine, Sendai, Japan
Heart failure (HF) is a global pandemic in Asia and Western
countries. Sex is an important contributor to the phenotypic
heterogeneity of HF. Women with HF are typically older, and
more often have hypertension, preserved left ventricular ejec-
tion fraction, and less ischemic heart disease as compared with
men. The significant underrepresentation of women in clinical
trials limits the capacity to evaluate the extent of sex-related
differences in HF. The Chronic Heart Failure Analysis and
Registry in the Tohoku District-2 (CHART-2) Study is a multi-
center, prospective cardiovascular observational study in Japan
(NCT 418 041). Among 4736 consecutive HF patients (mean
age, 69 years) in the CHART-2 Study, crude mortality rate was
comparable between women and men (52.4/1000 and 47.3/
1000 person-year for women and men, respectively, P ¼
.225), but women had a reduced risk of mortality after adjusting
for potential confounders (adjusted HR: 0.791; 95% CI: 0.640-
0.979, P ¼ .031). The incidence of cardiovascular death, par-
ticularly that due to HF, was significantly higher in women
than men. We also found sex difference in prognostic impor-
tance of statin therapy in patients with history of myocardial
infraction (n ¼ 3124): statin therapy was comparably related
with reduced incidence of death between both sexes but asso-
ciated with reduced incidence of HF admission only in men but
not in women (men: HR¼ 0.70, P< .001; women: HR¼ 0.98,
P ¼ .92, P for interaction ¼ 0.07). These observations indicate
that consideration of sex differences may provide more precise
cares for HF patients. In this session, we will discuss the current
insights into management of HF to maximize treatment bene-
fits with a special reference to sex difference.
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Multicenter Studies in Japan on Subjective
Symptoms and Diagnosis at Internal
Medicine in Consideration of Sex, Gender and
Age Differences in Medicine
Jinko Yokota1
1Tokyo Women’s Medical University, Health Care Center, Shinjuku-
ku, Tokyo, Japan
The General Internal Ambulatory Department plays a very
important role in local hospitals and the demand among the
inhabitants in Japan. We present hereby the second report
where we considered the problem of patients at the Internal
Medicine Ambulatory department from the standpoint of sex,
gender, and age. This is a cross-sectional retrospective study
conducted in the form of a unified medical examination sheet
questionnaire. We studied 6 local hospitals/infirmaries near the
metropolitan area, presenting us with data of new patients all in
the field of internal medicine. Thus, between June 15 and July
15, 2011 (summer period), and between January 16 and Feb-
ruary 15, 2012, we collected data from 4424 individuals. Those
individuals whose complaints we could analyze we grouped
according to sex and gender, age, and encoded according to
the Element No 1 of the second edition of International Clas-
sification of Primary Care. Of all, 3976 individuals were ana-
lyzed, 1335 in summer, 2641 in winter, 46.8% were male, mean
age 51.7 + 19.6 years. A split up according to complaints
yielded 43.3% “Respiratory,” which was the highest value fol-
lowed by “General and unspecified” (35%), “Digestive”
(30.9%), ”Neurological” (22.2%), and “Musculoskeletal”
(12.1%) in this order. Female patients had significantly more
troubles with digestive organs than men. The younger the
patients were the more they suffered from locally unspecified
troubles (or over the whole body), problems with digestive
tract, nerves, and respiratory organs. On the other hand, the
older the patients were the more they suffered from circulatory
dysfunctions. We studied the complaints of patients at the
Ambulatory Departments of community-based hospitals. We
are continuing our research about prognoses, diagnostic name,
and appropriate treatment at the time of the first examination.
Sex, Hormones and Macrophage Activation
in Cardiovascular Disease
Maria Luisa Barcena de Arellano1,2, Sofya
Pozdniakova1,2, Celine Christiansen1,2, Anja Kühl3, Istvan
Baczko4, Yury Ladilov1,2, and Vera Regitz-Zagrosek1,2
1Institute of Gender in der Medicine, Center of Cardiovascular
Research, Charité—Universitätsmedizin Berlin, Germany
2DZHK (German Centre for Cardiovascular Research), Partner site
Berlin, Germany
3Research Center ImmunoSciences (RCIS), Charité—
Universitätsmedizin Berlin, Germany
4Department of Pharmacology and Pharmacotherapy, University of
Szeged, Szeged, Hungary
Introduction: Aging is associated with deterioration of the phy-
siological function, leading to systemic inflammation and mito-
chondrial dysfunction that promote the development of
cardiovascular diseases. Sex differences in cardiovascular dis-
eases have been postulated. However, the exact mechanism of
these differences remains unclear. In the current study, we aimed
to investigate, whether there are sex and aged-induced differences
in the inflammation. We propose sex differences in the Sirt1-
AMPK axis and expression of mitochondrial proteins in young
hearts and that this differences are lost in age. Furthermore, we
propose a decreased mitochondrial biogenesis in aged female
hearts that promotes pro-inflammatory actions in old women.
Methods: Male and female human nondisease lateral left ventri-
cular wall tissue (men¼ 16 and female¼ 15) were used for qRT-
PCR, Western blot analysis, and immunohistochemistry. Sirt1,
AMPK, pAMPK, ac-Ku70, TFAM, PGC-1a, Sirt3, SOD2, and
catalase were used as parameters for mitochondrial biogenesis.
CD68 was used as marker for macrophages and the ratio of IL-12:
IL10 was used to examine the inflammatory stage in the heart.
Results: Sirt1 expression was significantly higher in young
females compared to young males (P < .05), whereas in aged
hearts Sirt1 expression was significantly downregulated in
females (P < .05). Accordingly to the Sirt1 downregulation in
aged females, Ku70 acetylation in aged female hearts was signif-
icantly elevated (P < .05). The activity of AMPK was signifi-
cantly decreased in aged individuals; however, no sex differences
in the AMPK expression or activity were found in young or in old
individuals. The expression of TOM40, SOD2, and Sirt3 was
significantly upregulated in young female compared to young
male (P < .05), while in aged female hearts SOD2 and TOM40
were downregulated. In addition, the expression of catalase, a key
cytosolic and mitochondrial antioxidative enzyme was signifi-
cantly higher in young females (P < .05) and this female sex
benefit was lost in aged hearts. In addition, the number of cardiac
macrophages was significantly increased in old female hearts
(P < .05). Accordingly with this, we found differences in the
IL12/IL10 ratio in young female cardiac tissue in favor of the
anti-inflammatory mediator IL-10 (ratio 1:4) compared to young
males (ratio 1:1). The anti-inflammatory environment in the heart
was lost in aged females (ratio 1:1). Conclusion: We conclude
that aging leads to a significant downregulation of Sirt1 expres-
sion and elevated acetylation of Ku70 in female, but not in male
hearts. Furthermore, a beneficial upregulation of mitochondrial
and antioxidative proteins in young females is lost with aging.
Moreover the malfunctions in the Sirt1 expression and mitochon-
drial proteins in aged female hearts is accompanied by a signifi-
cant pro-inflammatory shift, leading to an increase incidence of
cardiovascular diseases in old women.
Development of AI Diagnostic Navigation
System (WaiSE) for Women’s Medical Care
Assistance
Miyuki Katai1, Jo Kitawaki2, Shigeru BH Ko3, Teiji
Nishio4, Koji Oba5, and Mari Hotta Suzuki6
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1Department of General and Women’s Medicine, Tokyo Women’s
Medical University, Shinjuku-ku, Tokyo, Japan
2Department of Obstetrics and Gynecology, Graduate School of
Medical Science, Kyoto Prefectural University of Medicine, Kyoto,
Japan
3Department of Systems Medicine, Keio University School of
Medicine, Tokyo, Japan
4Department of Medical Physics, Graduate School of Medicine,
Tokyo Women’s Medical University, Tokyo, Japan
5Department of Biostatistics, Graduate School of Medicine,
The University of Tokyo, Tokyo, Japan
6Department of Health Services Center, National Graduate Institute
for Policy Studies, Tokyo, Japan
Women, especially at perimenopausal phase, often present
with a wide range of psychosomatic symptoms. Limited exam-
ination time often prevents a final diagnosis from being deter-
mined in general clinics. Therefore, women tend to repeatedly
visit multiple clinics with nonspecific symptoms. In Japan, an
estimation showed 18.8 billion yen spent annually on medical
expenses for perimenopausal women. Comprehensive support
that focuses on sex, gender, and age differences is desired.
Since 2007, Tokyo Women’s Medical University has provided
comprehensive women’s medical care based on gender medi-
cine, and diagnoses specific diseases in 27% of women with
nonspecific complaints. Therefore, based on our experience
with gender medicine, we decided to develop a tool using
artificial intelligence (AI) and a chatbot to support interview-
taking and diagnosis for women with nonspecific symptoms. In
April 2019, we began developing an AI diagnosis navigation
system “WaiSE” with support from the Japan Agency for Med-
ical Research and Development (AMED). WaiSE is an appli-
cation for patients and physicians that incorporates a chatbot
system with a diagnostic algorithm based on our clinical expe-
rience. In order to elucidate the pathology and establish evi-
dence for appropriate diagnosis and treatment for women’s
nonspecific symptoms, we will analyze data from 61 983 med-
ical records of 5241 patients who visited our Women’s Specific
Clinic at Tokyo Women’s Medical University over the past 10
years. WaiSE reproduces inquiries of Women’s Specific Clinic
experts in dialogue form through an AI chatbot system to orga-
nize complaints and guide users to the necessary information
for diagnosis. Women can use WaiSE to review information
about their chief complaint before attending a clinic and know
candidate of disease to be distinguished. They can share that
information with physicians in order to get differential diag-
noses and treatments. WaiSE is expected to improve patient
satisfaction, reduce medical expenses, and help women’s
health through more accurate diagnoses.
Sex Differences in Myocarditis and DCM:
A Personalized Medicine Approach for Men
and Women
DeLisa Fairweather, PhD, FAHA1
1Mayo Clinic, Department of Cardiovascular Medicine, Jacksonville,
FL, USA
Heart failure due to nonischemic dilated cardiomyopathy
(DCM) contributes significantly to the global burden of cardi-
ovascular disease. Myocarditis is, in turn, a major cause of
acute DCM in both men and women. However, recent clinical
and experimental evidence suggests that the pathogenesis and
prognosis of myocarditis and DCM differs between the sexes.
Men have an increased incidence and severity of most cardio-
vascular diseases including atherosclerosis, myocardial infarc-
tion, myocarditis, DCM, and heart failure, with the exception
of hypertension, which is higher in women. A recent study
found that myocarditis is 3.5 times more common in men than
women and DCM, regardless of cause, is around 2 times more
common in men. Men are more likely to require a heart trans-
plant following myocarditis and are at increased risk of death
compared to women. Animal models have provided valuable
information about the mechanisms that lead to more severe
myocarditis, DCM, and heart failure in men than women. We
recently showed that the biomarker sST2 only indicates risk of
heart failure in men under the age of 50 but not in women and
not in men over 50. This study highlights the need to examine
diagnostic and risk biomarkers and clinical end points accord-
ing to sex and age. Considering that sex hormones alter gene
expression that influences basic organ physiology, the immune
response to infection and damage, drug dose effects, and thus
symptoms and outcomes of therapy, a personalized approach to
medicine that incorporates the sex and age of the patient is
essential in order to provide effective health care.
Sex Differences in Mitochondrial Function
Renée Ventura-Clapier1, Jérôme Piquereau1, Vladimir
Veksler1, and Anne Garnier1
1Cardiovascular Signaling and Pathophysiology, UMR-S 1180
Inserm, Université Paris-Sud, Châtenay-Malabry, France
Mitochondria are unique organelles present in almost all cell
types. They are involved not only in the supply of energy to the
host cell but also in multiple biochemical and biological pro-
cesses like calcium homeostasis, production and regulation of
reactive oxygen species (ROS), pH control, or cell death. The
importance of mitochondria in cell biology and pathology is
increasingly recognized. Being maternally inherited, mito-
chondria exhibit a tissue-specificity, because most of the mito-
chondrial proteins are encoded by the nuclear genome. This
renders them exquisitely well adapted to the physiology of the
host cell. It is thus not surprising that mitochondria also show a
sexual dimorphism as that they are also prone to the influence
of sex chromosomes and sex hormones. Sexual dimorphism of
mitochondria involve mainly oxidative capacities, calcium
handling, and resistance to oxidative stress in a tissue-
specific manner. In turn, sex hormones regulate mitochondrial
function and biogenesis. Estrogens affect mitochondria through
multiple processes involving membrane and nuclear estrogen
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receptors (ERs) as well as more direct effects through signaling
pathways. Moreover, estrogen receptors have been identified
within mitochondria. Mitochondrial dysfunction is also an
important parameter for a large panel of pathologies including
neuromuscular disorders, encephalopathies, cardiovascular dis-
eases, metabolic disorders, neuropathies, renal dysfunction and
so on. Many of these pathologies present sex/gender specifi-
city. We will discuss the sexual dimorphism of mitochondria
from different tissues and how this dimorphism takes part in the
sex-specificity of important pathologies, mainly cardiovascular
diseases and neurological disorders.
La Pura Women’s Health Resort: Healthy
Aging and Well-Being Exclusively for Women
Sabine Fröhlich, MD1
1Medical Director of la pura, Women’s Health Resort, Gars am
Kamp, Austria
In the idyllic Gars am Kamp region, la pura presents itself as a
site of strength and energy only for women who consider a
healthy lifestyle just as important as ambiance. La pura is the
only resort just for women in all of Europe. It was founded
2011 and belongs to the VAMED company. Our gender med-
icine programs have been developed in cooperation with Alex-
andra Kautzky-Willer, Professor of Gender Medicine and Head
of the Division of Endocrinology & Metabolism of the Medical
University of Vienna. The Gender Institute in Gars enables sex
and gender-based research at La pura. The medical team at la
pura consists of general practitioners and specialists for trauma
surgery and orthopedics with additional education in osteopa-
thy, FX Mayr medicine, traditional Chinese Medicine,
homeopathy, and minimal aesthetic intervention and sports
experts as well as psychologists. The nutritional concept at la
pura is the GourMed® Cuisine. Valuable regional food prod-
ucts are prepared in a gentle way, using organic and seasonal
products. With our medical programs, we focus on prevention
of chronic diseases, a healthier lifestyle including individua-
lized healthy nutrition, exercise, and healthy aging and mental
health. As well we provide medical help and advice for
women-specific problems and female life-phases. We offer
detox programs for weight management and the FX Mayr cure
for regeneration of the digestive system—all under medical
supervision. Our healthy aging program includes 2 epigenetic
tests, on the one hand a metabolic panel and on the other hand a
biological age panel to find out any predispositions and risks to
premature aging. All programs are being perfected continu-
ously based on current evaluation and new knowledge to fur-
ther improve health and well-being of our female guests.
Inflammaging and Gender Differences
Giovannella Baggio1
1University of Padua, Italian Research Center for Gender Health and
Medicine, Padova, Italy
Human aging is characterized by a chronic, low-grade inflamma-
tion. This phenomenon has been called inflammaging, defined as
the chronic low-grade inflammation which is an important risk
factor for morbidity and mortality in the old people. Most if not all
age-related diseases have an inflammatory pathogenesis. Gender
differences in prevalence/incidence of diseases, clinical manifes-
tations, prevention strategies as well as in pharmacological needs
are very important. This may be most dependent on differences in
the inflammaging process. Is there a relationship between inflam-
maging and Frailty? And is there a difference between males and
females? Frailty is a state of reduced physiological reserve and
increased vulnerability for poor resolution of homeostasis after a
stressor event. The male-female health survival paradox may
bound to the fact that at any given age females have higher Frailty
Index (FI) scores than males. However females live longer than
males but with poorer health. In many papers a relationship
between frailty and cardiovascular diseases is described with
higher incidence but less mortality in females who are more
affected by obesity, diabetes, metabolic syndrome, coronary cal-
cifications, carotid plaques. Several papers conclude that biolo-
gical, behavioural, and social factors underpin sex differences in
frailty. However a great importance may be due to different
inflammaging processes: women have a lower susceptibility and
higher resistance to infection diseases in the first years of life, due
to a higher inflammation capacity. However in the adult and late
life, the high inflammation reaction of women leads more often to
immunological, atherosclerotic diseases, as well as to the so
called “degenerative” diseases (as osteoarthritis and dementia).
Longevity is a good balance between pro- and anti-inflammatory
stimula. And genetic component and great individual variability
influences frailty or robustness.
Sex and Gender Specific Phenotypes in
Alzheimer’s Disease—the Gateway to
Precision Medicine
Maria T. Ferretti1
1Institute for Regenerative Medicine, University of Zurich, Schlieren,
Switzerland
Sex differences in neurological and psychiatric diseases, notor-
iously heterogeneous in biology, clinical presentation and dis-
ease progression, have just started to be investigated and their
significance is currently debated. In this talk, I will provide an
overview of the literature documenting the occurrence and role
of sex differences in dementia, with a focus on Alzheimer’s
disease. Sex-differences in symptoms, biomarkers, risk factors,
and in response to medical intervention will be discussed. Fail-
ing to recognize and appropriately consider sex and gender
differences might compromise the development and validation
of optimal diagnostic and therapeutic tools for highly hetero-
genous diseases, such as Alzheimer’s. The Women’s Brain
Project advocates for more basic and clinical research into this
topic, in the context of a precision medicine approach that will
benefit both men and women.
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Metabolomic Profiles Differentiate Men and
Women in Accordance With Metabolic
Disease
Miriam Hufgard-Leitner1, Karoline Leitner1, Lena
Fragner2, Martin Brenner2, Xiauliang Sun2, Wolfram
Weckwerth2, and Kautzky-Willer1
1Department for Endocrinology and Metabolism, Gender Medicine
Unit, Medical University of Vienna, Vienna, Austria
2Department for Ecogenomics and System Biology, Vienna
Metabolomics Center, University of Vienna, Vienna, Austria
There is evidence that pathophysiology of metabolic syndrome
(MetS) differ between men and women. Sixty-six (33 female,
33 male) patients aged 60.3 to 62.5 years with (n ¼ 57) and
without (n ¼ 9) MetS, but without diabetes, were included in
the study. Each patient performed an oral glucose tolerance test
(oGTT). Untargeted metabolomics were measured fasting and
120 minutes after intake of 75 g glucose. Metabolic syndrome
was diagnosed by NCEP-ATIII criteria. Branched-chain amino
acids (BCAA) and fatty acids (FA) could be selected by a VIP
plot for MetS. A coefficients plot showed FA negatively cor-
related with MetS and BCAA positively correlated. Individual
amino acids (AA) were clustered in MetaFA and MetaBCAA.
Men had fewer MetaFA than women at time point 0 (LSD
Intervals: 0.6 vs 0.5); after 120 minute men had more
MetaFA than women (LSD intervals: 0.6 vs 0.4). Women
had fewer MetaBCAA at time point 0 (0.5 vs 0.5) and after
120 minutes (1 vs 0.9) after oGTT and MetaBCAA dropped,
while MetaBCAA in men rose after glucose intake. A boxplot
showed that MetaBCAA in women without MetS differed sig-
nificantly compared to MetaBCAA in women with MetS,
whereas no such difference could be shown for MetS in men.
Men had less MetaFA than women at time point 0 (0.7 vs
0.5), after glucose MetaFA increased in men (0.4) but
decreased in women (0.5). Men without MetS had a signifi-
cant different MetaFA profile than men with MetS, whereas
this could not be detected in women. Women without insulin
resistance (IR) had significant lower MetaBCAA than women
with IR (1 vs 1); men showed no differences in MetaBCAA
regarding IR; women with IR had more MetaBCAA than men
with IR (1 vs 0.3). Men with IR had significantly fewer
MetaFA than women with IR (1 vs 1.3). Spearman rank
correlations of single AA showed differences in untargeted
metabolomics between men and women. These results indicate
that metabolomics can distinct (patho)mechanisms of compo-
nents of MetS that differ between men and women. More
detailed analysis and exact requests in homogenous groups are
needed.
The Nuclear Membrane Estrogen Receptors
Define the Diagnosis and Treatment of
Gender Specific Medicine Disease
Edward M. Lichten, MD1
1Wayne State College of Medicine, Birmingham, MI, USA
Gender specific medicine (GSM) no longer is limited to
hypothesizing from observations of statistically significant cor-
relation between mankind’s gender and appearance of diseases.
Pierdominici’s discovered that loss of the estrogen receptor-
beta (ERb)/estrogen receptor-alpha (ERa) ratio correlated
directly with 90% of flairs of Crohn disease. Therefore,
researchers and clinicians have a reproducible biomarker that
directly links inflammation, hormones, GSM observations, and
treatments. Homeostatic ERb signaling maintains the anti-
inflammatory humoral state of IL-6, IL-10, and TNFa. As ERb
is a testosterone receptor, our clinical research directly links
loss of bioavailable testosterone in both sexes with loss of ERb
homeostasis and disease. In women with severe endometriosis,
the ERb/ ERa ratio is increased up to 100-fold. Considering
endometriosis as a GSM diseases limited to only women, the
prescribe anabolic steroids, actions similar to danazol, reset the
ERb/ ERa ratio biomarkers downward. The 2 biomarkers used
are bioavailable testosterone (Free Androgen Index) and the
ERb/ ERa ratio. This differs from Crohn disease in which men
and women are both affected, yet, remissions have occurred in
both sexes with anabolic medications that reset the low ERb/
ERa ratio, upward. This information has almost unlimited
applications: the clinician defines the disease, measures the
aforementioned serum biomarkers, and treats the patient in
parallel to the in vitro findings from the individual’s T-
lymphocytes tissue culture. The ERb/ ERa ratio and 8 cyto-
kines testing are repeated 8-weeks after various drug therapies.
This is the future of precision medicine: direct treatment indi-
vidually based on in vitro biomarkers. The ERb/ ERa ratio
should be adopted as the biomarker for all GSM research: it
separates diseases limited to only women such as endometrio-
sis, breast and ovarian cancer, and directs a new course of
understanding and potential future treatments in diseases that
affect both sexes.
Large-Scale Screening of Organ-Specific
Autoantibodies in Patients With
Autoimmune Thyroid Diseases
Porcelli Brunetta1, Civitelli Serenella2, Tabucchi
Antonella1, Pini Alessandro1, Cinci Francesca1, Terzuoli
Lucia1, Bacarelli Maria Romana2, Cantara Silvia2,
Dalmazio Gilda2, Scapellato Carlo1, Castagna Maria
Grazia2, and Pilli Tania2
1Department of Medical Biotechnologies, University of Siena, Siena,
Italy
2Department of Medicine, Surgery and Neuroscience, University of
Siena, Siena, Italy
Background: Multiple autoimmune syndromes (MAS) are dis-
eases characterized by autoimmune activity against more than
one endocrine organs, although nonendocrine organs can be
affected. Four types of MAS have been described: MAS type
10 Gender and the Genome
1 (at least 2 among chronic candidiasis, chronic hypoparathyr-
oidism, Addison’s disease); MAS type 2 (Addison’s disease
plus autoimmune thyroid disease [ATD] and/or diabetes mel-
litus type 1); MAS type 3 (ATD plus other autoimmune dis-
eases); and MAS type 4 (association of diseases that do not fit
in type 1, 2, and 3). It is well recognized the prevalence of
female in the MAS, but an analysis of the frequency of the
single antibodies in female and male has never been reported
in literature. The aim of our study was to establish the preva-
lence of organ-specific autoantibodies: antiadrenal (ACA),
antiovary (StCA), antipituitary (APA), antiparietal gastric cells
(PCA), antitransglutaminase (AtTG), antiglutamic acid decar-
boxylase (GAD), and antimuscle nicotinic acetylcholine recep-
tor (ARAb) in patients with ATD. Experimental methods: A
total of 1629 patients (1419 F, 210 M, age: 50.6 + 14.7) with
ATD have been prospectively enrolled. ACA, StCA, APA, and
PCA were measured by indirect immunofluorescence assay
(Euroimmun, Germany), AtTG by a fluorescence enzyme
immunoassay (Phadia, Sweden), GAD by an enzyme immu-
noassay (Technogenetics, Italy), and Arab by a radioimmu-
noassay (RSR, United Kingdom). Results: Antiadrenal
autoantibodies were positive in 11 patients (10 F, 1 M), StCA
in 6 F, APA in 9 patients (8 F, 1 M), PCA in 151 patients (129
F, 22 M), GAD in 67 patients (51 F, 16 M), AtTG in 11 female,
and ARAb in 5 patients (4 F, 1 M). Only GAD was significantly
associated with males (P ¼ .015). Conclusions: Our results
show that there is no difference of the prevalence of the ana-
lyzed organ-specific autoantibodies in patients with ATD
regarding gender, as already reported, except for GAD.
Gender Differences in Osteoporosis
Ginaldi L1, Sirufo M M1, Di Silvestre D1, and De Martinis
M1
1Department of Life, Health and Environmental Sciences, University
of L’Aquila; Allergy and Clinical Immunology Unit, AUSL 04 Teramo,
Italy
Background: Osteoporosis is characterized by low bone
mineral density (BMD) and increased risk of fractures. In Italy
osteoporosis affects about 5 000 000 people, of which 80% are
postmenopausal women. Men are underdiagnosed and inade-
quately treated, although osteoporotic fractures in men are
accompanied by greater mortality compared to women. Objec-
tives: To assess gender differences in BMD, bone remodeling
serum markers and fractures in subjects observed at the out-
patient Center for Osteoporosis of L’Aquila University. Meth-
ods: We evaluated 749 females (65.29 + 10 years) and 43
males (66.62 + 10.99). Calcium (Ca), phosphorus (P), para-
thyroid hormone (PTH), 25(OH) vitamin D (vit D), beta-cross
laps (CTX), osteocalcin, bone alkaline phosphatase (BAP),
erythrocyte sedimentation rate (ESR), C-reactive protein
(CRP), and lumbar/femoral BMD (T-score) were measured.
Results: Women showed lower vit D, CTX, and PTH serum
levels than men (25.31 + 15.17 ng/mL vs 32.97 + 21.90 ng/
mL, 389.07 + 453 pg/mL vs 441.28 + 343.37 pg/mL and
59.82 + 39.18 pg/mL vs 60.17 + 43.11 pg/mL, respectively;
P < .01). Serum P levels and ESR were lower in men than
women (2.90 + 0.56 mg/dL vs 3.37 + 0.52 mg/dL and 14.59
+ 12.31 mm/h vs 19.85 + 14.36 mm/h, respectively; P< .01).
No difference in the other parameters was observed. Bone
mineral density was lower in females (mean T-score level
2.33 + 1.14) compared to males (31 + 1.55; P < .01).
The prevalence of osteoporosis (T-score<2.5) was higher in
females compared to males (51.26% vs 27.90%; P < .05),
whereas the percentage of fractured patients was higher in
osteoporotic men than women (50% vs 30.72%). Conclusions:
Bone mineral density is higher in men than women of compa-
rable age. However, osteoporotic fractures are higher in men
than women. CTX, PTH, and vit D are lower and ESR is higher
in women than men.
Sex Differences in Gastrointestinal Cancers
Anna D. Wagner, MD1, Berna Oezdemir, MD, PhD1,
and Sabine Oertelt-Pirigione, MD, PhD2
1Department of Oncology, Lausanne University Hospital and
University of Lausanne, Lausanne, Switzerland
2Radboud Institute of Health Sciences (RIHS), Department of
Primary and Community Care, Radboud University Medical Center,
Nijmegen, the Netherlands
So far, oncology has been largely sex- and gender-blind. How-
ever, together with the interest in personalized oncology and
our improved understanding of cancer biology, sex differences
in cancer epidemiology and distribution of molecular subtypes
of various cancer types (eg, gastroesophageal cancer) as well as
patient outcome are gaining increasing attention. In addition,
recent evidence suggests significant sex differences in efficacy
and toxicity of certain chemotherapies, alone or when used in
combination with biologicals. The European Society for Med-
ical Oncology (ESMO) is addressing this challenge. After an
initial workshop “Gender medicine meets oncology” held in
2018, ESMO created a multidisciplinary task force which will
define key research projects to investigate the effect of sex and
gender on cancer epidemiology and outcomes, as well as treat-
ment effects and communicate relevant findings at future
meetings.
Drug-Utilization Pattern of Non Small Cell
Lung Cancer Patients Related to Gender at
the University Hospital of Siena, Italy
Spini Andrea1,2,3, Salvo Francesco3, Roberto Giuseppe4,
Ciccone Valerio1, Pascucci Alessandra2, Rosellini Pietro2,
Francini Edoardo5, Donnini Sandra1, Gini Rosa2, and
Ziche Marina1,2
1Università degli studi di Siena, Siena, Italy
2Azienda Ospedaliera Universitaria Senese, Siena, Italy
3Université de Bordeaux, Bordeaux, France
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4Agenzia Regionale di Sanità della Toscana, Firenze, Italy
5Università “La Sapienza”, Roma, Italy
Lung cancer is the third most commonly occurring cancer in
females. Non-small cell lung cancer (NSCLC) represents about
85% of all cases of lung cancer. Recently, treatment guidelines
for NSCLC have changed due to the introduction of new drugs
for patients with advanced stage of the disease. The aim of the
study was to analyze the treatment patterns of patients diag-
nosed with NSCLC between 2009 and 2017 at the University
Hospital of Siena (UHS), focusing on gender difference in drug
utilization. Patients with NSCLC diagnosis were identified by
records in the pathology registry (PR) of UHS. Pathology reg-
istry data of NSCLC patients were anonymized and linked to
the administrative health-care database of Tuscany region.
Advanced stage patients were defined as those without surgical
intervention (NO-SUR patients). A total of 2003 NSCLC
patients were identified. There was a statistically significant
upward trend (P ¼ .0177) in the incidence in women, rising
from 25% in 2009 to 38% in 2017. The average age of patients
was 69 years and 45.3% were aged between 50 and 69 years;
NO-SUR were the 57.1% of the study cohort (n ¼ 1144). This
cohort was divided in elderly, aged  70 years (n ¼ 587), and
young patients, aged 18 to 69 years (n ¼ 557). In the 6 months
following the index date, the percentage of subjects who
received both immunotherapy and target therapy was higher
among young patients, 5.9% vs 1.7% and 13.1% vs 11.1%,
respectively and increased from 2.8% to 28.2% in young
patients (P < .001) and from 1.4% to 6.9% in elderly patients
between 2015 and 2017. In this cohort, the proportion of
women increased. Data will be presented on the pattern of drug
utilization and outcome in relation to gender. Real-world data
on the pattern of drug utilization provide important information
for clinician and health provider both in terms of appropriate-
ness and economic sustainability of care.
X-Chromosome-Linked miR-548am-5p Is a
Key Regulator of Mitochondria-Mediated
Apoptosis and Is Implicated in XX and XY
Cell Disparity
Paola Matarrese1, Paolo Tieri2, Simona Anticoli1, Barbara
Ascione1, Maria Conte3,4, Claudio Franceschi5, Walter
Malorni1,6, Stefano Salvioli3,4, and Anna Ruggieri1
1Center for Gender Specific Medicine, Istituto Superiore di Sanità,
Rome, Italy
2National Research Council, Rome, Italy
3University of Bologna, BO, Italy
4Interdepartmental Centre “L. Galvani”, Bologna, Italy
5Neurological Sciences Institute Bologna, Italy
6University of Tor Vergata, Rome, Italy
The relevance of sex dimorphism in cell response to stress has
previously been investigated by different research groups. It
has been reported that, under the same stressing conditions,
XY cells easier undergo cell death in comparison with XX cells
that easier undergo cytoprotection by autophagy. This
dimorphism could be due, at least in part, to regulatory ele-
ments such as microRNAs (miRs). In order to point out miR
expression differences, we took advantage of specialized data-
bases to identify X chromosome-encoded miRs potentially
escaping X chromosome inactivation (XCI). One of these, the
MiR-548am-5p, was found as a potential XCI escaper. This
MiR is also deeply related to cell fate paths. We found that
experimentally induced overexpression of miR548am-5p in
XY cells by lentivirus vector transduction decreased apoptosis
susceptibility, whereas its downregulation in XX cells
enhanced apoptosis susceptibility. These data suggest that miR
identified with this approach, miR548am-5p, can account, at
least in part, for sex-dependent differences observed in the
susceptibility to mitochondria-mediated apoptosis of human
cells. More in general, these results also underscore the rele-
vance of X chromosome-encoded miRs escaping XCI in cell
pathology and the possible key roles of epigenetic mechanisms
in determining XX and XY cell fate disparity.
Global Health and Gender Education:
A Multidisciplinary Approach
Serenella Civitelli1 and Alessandra Viviani2
1Department of Medical, Surgical and Neurological Sciences,
University of Siena, Italy
2Department of Political and International Sciences, University of
Siena, Italy
Global Health is a concept that apply to the vision of health and
disease as a result of many factors related to biological or
individual characteristics but also to social, economic, and
environmental conditions. Introducing gender issues in educa-
tional programs for health professionals may be useful but
global health may be improved only through a multidisciplin-
ary commitment aimed at creating a wider gender perspective
about access to health care, decent work, and representation in
political and economic decision-making processes. In the Glo-
bal Gender Gap Index 2018, Italy ranks 82nd out of 144 Coun-
tries and 118th in economic participation and opportunity
subindex. “Gender equality” is the fifth out of 17 goals of the
UN 2030 Agenda for Sustainable Development. Based on the
premises that global health inequalities cannot be overcome by
simply focusing on medical field but that an encompassing
cultural change is needed, a group of teachers of different
Departments (Law, Social sciences, Medicine) of the Univer-
sity of Siena decide to run the first comprehensive educational
program addressed to students, both graduated and undergrad-
uated, and to University and Municipality staff. Following pre-
sentations of statistics, scientific data and academic research in
various disciplines, students were invited, also through non
formal education tools, to openly discuss about their beliefs,
feelings, and ”unconscious” gender stereotypes to enhance
their critical thinking skills. The exams’ results of the pilot
course held in May demonstrate students’ increased interest
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and understanding of the multiple levels of gender issues and
the need for gender mainstreaming in all fields of social life.
Focus Gender—Medical Students Gender
Specific Perception and Attitudes Towards
Burdens of the Everyday Student Life
Steiner-Hofbauer Verena1, Capan Melser Mesküre1, and
Holzinger Anita1
1Medizinische Universität Wien, Research Unit für Curriculument
wicklung, Wien, Austria
The aim of this study was to investigate whether female and
male medical students perceive burdens differently and
whether students of both sexes assess their capability to stand
performance pressure differently. In 2017, second (n ¼ 424,
53% female) and sixth (n ¼ 161, 46.6% female) year students
at the medical university of Vienna were surveyed using a fully
structured questionnaire. In second year, female students felt
significantly more often that they could not measure up to study
requirements than male students (87.5% vs 94.4%). Perfor-
mance pressure was perceived as major problem by male
(45.5%) and female (50.9%) students, while in sixth year the
number was only half as high than in second (24%, 18.4%). In
sixth year, significantly more female than male students were
complaining about competition between students (33.3% vs
8%). Half of the students shared the view that there is no
difference between men and women in the capability to deal
with performance pressure. Most of the other half state that
men are superior to women in handling performance pressure.
In both groups, significantly more male than female students
were convinced that they are superior to the other sex in han-
dling performance pressure. Perception of problems is similar
in male and female students. While in objective assessments,
female students perform equally to male students they consider
themselves less competent and are more inclined to doubt their
capability.
Gender Integration in the Pregraduate
Medical Curricula: A Swiss Perspective
Alexina Legros-Lefeuvre1, Virginie Schlüter1, Joëlle
Schwarz1, and Carole Clair1
1Gender and Medicine Unit, Department of Training, Research and
Innovation, Center for Primary Care and Public Health (Unisanté),
University of Lausanne, Switzerland
Introduction: Integrating gender perspective in the medical
curricula has been proved to be of the utmost value in order
to address the health inequities created by gender bias. Follow-
ing the insertion of gender sensitive objectives in the 2018-
revised Swiss catalog of medical learning objectives (Profiles),
the integration of gender in the medical curricula of the Uni-
versity of Lausanne has been facilitated. This integration pro-
cess, driven by the Gender and Medicine Unit, focuses on 2
axes: content (evidence-based gendered medicine) and form
(gender neutral/nonstereotyped teaching material). Hypoth-
esis: Using a multilevel strategy in clinically relevant medical
education disciplines facilitates the integration process. Proj-
ect Description: First, a Gender and Medicine Commission
composed of 12 academic representatives from different med-
ical disciplines has been created. Then, information about the
new gender objectives set in the profiles was sent to every
discipline leader. Integration was progressively launched
through a strategic selection of disciplines (cardiology, abdom-
inal surgery, oncology, pediatrics, and psychiatry) based on 2
facilitating factors: pertinence in gender integration and avail-
able literature; and a listing of gender supportive faculty mem-
bers or teachers. Subsequently, we conducted a review of
literature and teaching material to address predefined disci-
plines’ leaders and teachers in order to provide specific and
practical material for gender integration. This project aims to
communicate broadly on the processes and outputs in order to
incite other disciplines to endorse evidence-based gender inte-
gration. Conclusion: As shown by previous international
experiences, gender integration is effective but requires a mul-
tilevel strategy. The focus on pregraduate students is pertinent
as it will ultimately improve care for all patients.
Integrating a Gender Perspective into Core
Curriculum of Medical Students
Serenella Civitelli1, Rosa D’Amico1, Brunetta Porcelli2,
and Piersante Sestini1
1Department of Medical, Surgical and Neurological Sciences,
University of Siena, Italy
2Department of Medical biotechnologies, University of Siena, Italy
Integrating gender issues into curriculum and underlining the
influence of gender in personal and professional choices is
necessary to promote gender equality in medicine. Several
years ago, an optional course on Gender Medicine was run at
the University of Siena on request of a teacher who aimed to
raise awareness about the influence of gender on health and
illness, choice of specialization, professional and social rela-
tionships. Following students’ interest, “Gender health” was
then introduced into the second year core curriculum as a mod-
ule within the Integrated Course of “Medico-scientific metho-
dology, human sciences and health promotion.” A gender
perspective was applied in reviewing the medical literature,
discussing the role of women in the history of medicine and
surgery and the concept of gender as a determinant of health
and a topic of scientific relevance. The final examination con-
sisted of a written paper on the treated topics with a free-form
reflection. Afterward, according to the Faculty policy, all stu-
dents must fill out an online anonymous, semistructured satis-
faction questionnaire. In all, 658 students (404 F; 254 M)
attended the MSSUP from 2016 to 2019 and most of them
stated their satisfaction with the course as a whole. The module
of “Gender Health” received the highest rating in all 3 years
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(4.8 in a 5 level scale). Students of both sexes declared great
interest for gender issues that were referred to as relevant for
their clinical practice and social commitment. Young people
have a desire to learn and fertile minds. Persons in leadership
positions have to be engaged to introduce a gender perspective
in formal education. Competent and gender sensitive teachers
are important as well. All staff and educators have to become
aware of scientific relevance of gender differences to integrate
such knowledge in every class and discipline.
A Conceptual Framework: Gender Medicine
Versus Gender of Medicine
Gamze Aktuna, MD1
1Hacettepe Universitesi, Halk Sagligi Enstitüsü, Sihhiye, Cankaya,
Ankara, Turkiye
In this study, the physicians’ opinions about “Gender of Med-
icine” and ”Gender Medicine” were evaluated from the
answers of the survey question conducted for physicians and
medical faculty students. Over the years, the effects of gender
on medicine became more observable. It has been possible for
women to be involved in the medical profession just in the last
centuries. Like women, LGBTþ individuals also experience
various problems in medical practice. On the other hand, in
every step of medical practices Gender Medicine Vision’s sig-
nificance is a crystal-clear fact. In this descriptive study, the
universe is the physicians in Turkey; sample size is not calcu-
lated and purposive and snowball sampling methods were used.
Through social media and communication tools, open access
online questionnaire was shared and volunteers answered. This
study conducted via the last question which is “In your opinion,
what is the difference between ‘Gender of Medicine’ and ‘Gen-
der Medicine.’” Of all, 908 people participated in the question-
naire, and the 2 conceptual frame, from the view of semantics,
inference and differences were discussed with the coding of
answers. As a result of coding, few main themes were revealed
as Medicine is a little Man growing with patriarchy, doctor’s
sexual identity versus Patients’. The main outcome point of this
research is that physicians may differ in their perception of the
gender of their own professional discipline and knowledge of
“Gender Medicine” that may shed light on the future of medical
practices.
Reflexivity on Gender Bias in Clinical
Practice: A Tool for Medical Education
Implemented in Switzerland
Joëlle Schwarz1, Elisa Geiser1, and Carole Clair1
1Gender and Medicine Unit, Department of Training, Research and
Innovation, Center for Primary Care and Public Health (Unisanté),
University of Lausanne, Switzerland
The Medical School of Lausanne, Switzerland, includes a gen-
der medicine theoretical teaching that aims at “fixing the
knowledge” on sex and/or gender differences in medicine. In
2019, a pilot project was introduced to integrate reflexivity on
the influence of gender in clinical practice. The aim was to
raise students’ awareness on gender bias and the potential
effect on patients’ management. Reflexivity is the ability to
critically reflect on and assess one’s own presuppositions and
social experiences that shape one’s perceptions and actions. By
reflecting on one’s gender perceptions, the hypothesis is that
gender bias (gender stereotyping [treating men and women
differently but not clinically relevant] or gender blindness
[treating men and women equally when clinical differences
exist]) may be reduced in clinical practice. During their intern-
ship, medical students discuss the case management an encoun-
tered clinical case with a chief resident, in small groups. A
gender lens was introduced whereby students are asked to dis-
cuss the case considering potential gender bias, with support
from a gendered medicine expert. In a second step, students are
asked to fill an online reflexivity sheet, presenting their dis-
cussed clinical case and reflecting individually on potential
gender bias and lessons learned. Their assessment is commen-
ted and validated by a gendered medicine expert. Topics dis-
cussed in groups and in reflexivity sheets can be grouped in
different categories: the relevance and use of epidemiological
data (gender difference in disease prevalence) for patient man-
agement; medical knowledge on evidence-based gender differ-
ences, by pathology; gender bias at different steps of a
consultation: anamnesis (gender stereotypes assessing psycho-
social background); clinical exams (influence of gender on
clinician-patient interactions); differential diagnosis (driven
by evidence-based or stereotyped-gender differences); treat-
ment (gender differences in pain management). Reflexivity is
a powerful tool to raise awareness on one’s own gender percep-
tions and potential bias that may impact clinical practice.
The Relevance of Hidden Curriculum in
Health Professional Formation
Serenella Civitelli1, Ferretti Fabio1, Anna Coluccia1,
Roberto Gusinu2, and the Gender Health and Medicine
Group of the University Hospital of Siena3
1Department of Medical, Surgical and Neurological Sciences,
University of Siena, Italy
2Santa Maria alle Scotte University Hospital of Siena, Siena, Italy
3University Hospital of Siena, Siena, Italy
Background: Gender awareness is mandatory to improve
medical practice and to maintain good relationships with
patients and colleagues. Different strategies have been pro-
posed to integrate gender issues in formal medical education
but the hidden curriculum, conveyed by official and unofficial
teachers, is important as well. Aim of the Study: To assess
gender sensitivity and basic knowledge about gender differ-
ences in medicine in persons involved in formal and nonformal
training of health-care professionals (HP). Methods: An anon-
ymous, semistructured questionnaire has been e-mailed to 1975
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HP of the University Hospital of Siena where HP trainees
attend for internship. Results: A complete questionnaire was
returned by 148 (7.49%) HP (39 M, 139 F). One fourth of
respondents have a teaching assignment at the University of
Siena and half of them claims to have introduced gender issues
in class: 45% of those who do not state the topic is not relevant
for their discipline. Slight differences between men and women
are noted in answers related to knowledge of gender differences
in the incidence of breast (17%), colorectal (37%), and lung
cancer in never-smokers (8%); < 12% knows that scientific
studies have been mostly conducted on men, male animals, and
male cells; 52% are aware that woman’s symptoms of the same
disease are often different from a man’s; 75% believe that her
perception of illness may be different. Stereotypical thinking
about communication style of both patients and doctors and
between them is also shown. Conclusions: Increasing gender
sensitivity in HP is necessary not only to improve quality of
care but also to avoid that prejudices and stereotypical thinking
may be transmitted to younger generation through the hidden
curriculum. Commitment of hospital managers in addition to
that of Faculty Members is of utmost importance.
Gender Medicine in the Programs of the
Italian Public Institutions: The Role of
FNOMCeO
Teresita Mazzei1, Filippo Anelli2, and Franco Lavalle3
1Florence Medical Council and FNOMCeO Gender Medicine
Committee, Italy
2FNOMCeO President, Rome, Italy
3Bari Medical Council and FNOMCeO Gender Medicine Committee,
Italy
Background: About 400 000 active medical doctors of the
Italian health system did not receive any pregraduate education
on Health and Gender Medicine. Since June 13, 2019 in Italy
we have, first country in Europe, a specific law for the appli-
cation and diffusion of Gender Medicine in the National health
system. FNOMCeO (National Federation of the Orders of Doc-
tors and Dentists) is a public Institution, subsidiary of the State,
whose main purpose is to update the Code of Ethics for Italian
physicians and to check that they respect it. According to the
Code of Ethics, the post graduated-education on Gender Med-
icine is mandatory. Methods: Both FNOMCeO and the Pro-
vincial Medical Councils are accredited providers for
Continual Medical Education and they have been organizing
residential postgraduate training courses for several years. In
2014, FNOMCeO set up a specific Committee for Health and
Gender Medicine composed of both experts and Presidents or
Vice-Presidents of the Local Medical Councils. The aims of the
Committee are to plan postgraduate training courses, to inform
citizens, to take part to the National and International Network
for Gender Medicine, to cooperate with other Italian Public
Institutions, and to encourage clinical research. Results: Since
2014, this Committee has been organizing 20 residential
courses, workshops, and it has been taking part of symposia
organized by the most important National Scientific Societies
(eg, general practitioners, hospital doctors, etc). In the last 10
months, Italian medical doctors or dentists have received more
than 28 000 CME credits through a FNOMCeO Course in
Distance Learning (F.A.D.). Conclusions: In consideration to
the need of implementing postgraduate education on health and
Gender Medicine for Italian physicians, FNOMCeO is coop-
erating with other Public Institutions (University, Scientific
Societies, Regional and National Governments, etc) to promote
an adequate post graduated-education on Gender Medicine.
Health and Gender Medicine: a Cutting-Edge
Formative Experience Promoted by the
University of Florence
Michela Cirillo, MSc1, Linda Vignozzi2, Domenico Prisco1,
Teresita Mazzei3, and Cinzia Fatini, PhD1
1Department of Experimental and Clinical Medicine, University of
Florence, Italy
2Department of Experimental Clinical and Biomedical Sciences
“Mario Serio”, University of Florence, Italy
3Department of Health Sciences, University of Florence, Italy
Background: There has been an increased awareness that
gender-specific issues influence women’s and men’s health more
broadly and with a higher impact than previously recognized.
These differences are not limited to reproductive health, but
extend to almost every other organ and tissues. The University
of Florence promoted education in health and gender medicine,
which is targeted at students of bachelor and master programs as
well as at postgraduate students, clinicians, academicians, and
researchers. Methods: In the pregraduate education, gender med-
icine has been recognized as an integral and suggested part of the
core curriculum for students in all medical schools; it is repre-
sented in the teaching programs of the School of Medicine and
Surgery in Italy. In postgraduate education, master is an example
of truly interdisciplinary collaboration, staffed by academics from
a range of disciplines, each bringing their specific expertise to
bear on the topics under discussion. It is intended for all health
science professionals with a university master degree in medicine,
dentistry, pharmacy, biology, nutritional sciences, nursing, psy-
chology or sociology, interested in gender-specific health issues
and its program features 4 taught modules, followed by an experi-
mental thesis. Results: From 2017, School of Medicine of Flor-
ence initiated pregraduate education by in-room teaching, several
educational courses, and workshops. From 2016 to 2018, 17 pro-
fessionals brilliantly completed their postgraduate course of stud-
ies. In the academic year 2018-2019, 10 participants are obtaining
specific expertise on health and gender medicine topics. Conclu-
sion: The implementation of gender medicine into clinical prac-
tice is dependent on the adaptation of pregraduate and
postgraduate medical education to these principles. The educa-
tion in this field is the keystone for understanding and applying
gender medicine principles. The University of Florence paved the
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way to support and encourage the development of gender medical
clinical and preclinical research.
Gender Medicine Multimedia Library: An
Apulian Experimental Project
Anna Maria Moretti1, Orazio Valerio giannico2, and
Annavita Perrone3
1GISeG and GVM Santa Maria Hospital, Bari, Italy
2Department of Biomedical Sciences and Human Oncology,
University of Bari Aldo Moro, Bari, Italy
3Director of the Library and Institutional Communication Section of
the Apulia Regional Council, Bari, Italy
Background: The Multimedia Library of Gender Medicine is a
new section of Apulian Regional Council Library “Teca del
Mediterraneo” created by Giseg (“Gruppo Italiano Salute e
Genere”), in collaboration with Apulian Regional Council,
with the aim of become an efficient, qualified, and reliable
cultural reference center for gender medicine in terms of infor-
mation, research, and documentation.
The main objectives of this structure are:
 develop knowledge of gender issues and undertake
health education initiatives
 promote scientific and research activities
 carry out training programs for professional develop-
ment and ongoing training
 correctly inform citizenship of related issues through the
use of correct information dissemination channels
 construct a qualified gender point of view on the set of
pathologies affecting women and men
 highlight the centrality of the “gender approach” in
medicine.
Methods: The project involves the collection and catalo-
ging of the available literature on gender medicine and the
availability of online material for both health workers and cit-
izens interested in the subject. In addition to the scientific
material, the multimedia library will also offer training and
information spaces, with educational material, training courses,
and events on the subject, both for those who work in the health
sector and for citizens who want to learn more about the sub-
ject. Will be available, for example, short informative videos,
“Pills” of gender medicine. Results: On September 1, 2018, a
protocol on gender medicine was signed between the GISeG
and the Regional Council of Apulia. The multimedia library is
now online and available at this link: http://biblioteca.consi
glio.puglia.it/dettaglio/menu/4522/Medicina-di-genere
[Accessed Jun 29, 2019]. Conclusion: We hope the library will
play an important role in increasing and supporting participa-
tion in gender medicine projects, becoming a service center for
information and advices to any public or private subject inter-
ested in the subject.
Reporting of Sex-Specific Outcomes in Trials
on Cardiovascular Disease: Where Is the
Progress?
M. M. Schreuder, BSc1, E. Boersma, PhD2, M. Kavousi,
MD3, L. E. Visser, PhD3, J. W. Roos Hesselink, MD2, J.
Versmissen, MD1, and J. E. Roeters van Lennep, MD1
1Department of Internal Medicine, Division Vascular Medicine,
Erasmus MC, Rotterdam, the Netherlands
2Department of Cardiology, Erasmus MC, Rotterdam, the
Netherlands
3Department of Epidemiology, Erasmus MC, Rotterdam, the
Netherlands
Background: Past decade attention of the importance of sex
and gender-specific medicine has increased. However, whether
this has led to tangible results regarding reporting sex and
gender in publications is uncertain. Our aim is to determine
whether reporting efficacy and safety data stratified by sex in
major cardiovascular trials has increased between 2010 and
2017. Methods: We reviewed the availability of sex-specific
data of the publications of cardiovascular drug trials which
































































Figure 1. Sex-specific analyses on efficacy and safety.
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of the European Society of Cardiology (ESC), the “Late Break-
ing Clinical Trials” of the American Heart Association (AHA)
and the American College of Cardiology (ACC) in 2010 and
compared these with 2017. Sex-specific data was assessed sep-
arately for efficacy and safety (adverse events) end points.
Moreover we assessed the percentage of sex-specific data per
publishing journal, conference, and sex of the first author.
Results: In total, we included 29 in 2010 and 34 trials in
2017. The mean percentage of female participants was 32.8%
in 2010 vs 33.4% in 2017. In 2010, efficacy and safety end
points were reported per sex in 34.5% and 11.1% of the trials vs
23.5% and 8.8% of the trials in 2017. Only ACC showed
improvement in reporting of sex-specific efficacy end points
(37.5% to 50%) (Figure 1). Of the journals, the New England
Journal of Medicine had the highest percentage of studies
reporting sex-specific end points (2010: 41.7% vs 2017:
54.5%). Studies with a female first author did not report more
often sex-specific data compared to those with a male first
author. Conclusion: Despite the growing awareness of the
importance of sex and gender, reportage of sex-specific effi-
cacy and safety in cardiovascular drug trials has not improved.
Specific guidelines and checklists issued by scientific societies
and journals regarding reporting sex and/or gender specific
data could help to improve this shortcoming.
Role of Endometriosis in Defining
Cardiovascular Risk in Women:
An Interdisciplinary Approach of Gender
Medicine
Michela Cirillo1, Maria E. Coccia2, Tiziana Ciarambino3,
Francesca Rizzello2, and Cinzia Fatini1
1Department of Experimental and Clinical Medicine, University of
Florence, Italy
2Center for Assisted Reproductive Technology, Division of Obstetrics
and Gynecology, Careggi University Hospital, Florence, Italy
3Department of Internal Medicine, Hospital of Marcianise, ASL
Caserta, Italy
Background: The relationship between endometriosis and
subclinical atherosclerosis represents an emergent topic in
women’s health, as women with endometriosis are at higher
risk of cardiovascular (CV) disease later in life. Objective: We
investigated metabolic and endothelial markers of athero-
sclerosis, and the association between atherosclerotic burden
and clinical endometriosis degree. Methods: The study popu-
lation comprised 660 women framed for CV risk. Results: In
all, 109 women (16.5%) had endometriosis and showed an
altered lipid profile, and increased homocysteine values in
comparison to that observed in women without endometriosis.
By analyzing CV profile according to degree of endometrial
involvement, 92 women (84.4%) had stage III/IV, whereas
15.6% had stage I/II. We observed a significant difference of
lipid profile in stage III/IV in comparison to that observed in
stage I/II of endometriosis (P < .05), as well as lower vitamin
B6 and folate (P ¼ .01 and P ¼ .03, respectively) values, and
higher hs-CRP concentrations (P ¼ .04). After adjustment for
traditional CV risk factors (OR ¼ 5.24, P ¼ .02), the worsen
lipid profile remained significantly associated with severity of
endometriosis. Conclusions: Our findings provide evidence of
an unfavorable vascular profile related to pictures of accelerated
atherosclerosis, possibly representing the common mechanism
shared by a gynecological disorder and CV disease, and contri-
buting to clarify the role of endometriosis as a gender-specific
CV risk factor. The clinical relevance of our study lies in identify
women with stage III/IV of endometriosis at higher risk of ather-
osclerotic disease, who could have a greater benefit for an early
CV screening for controlling future CV risk.
Sex Differences in Prognostic Impacts of
Serum Uric Acid Levels in Heart Failure—
Insights From the CHART-2 Study
Takahide Fujihashi1, Yasuhiko Sakata1,2, Kotaro
Nochioka1,2, Hajime Aoyanagi1, Shinsuke Yamanaka1,
Hideka Hayashi1, Takashi Shiroto1, Koichiro Sugimura1,
Jun Takahashi1, Satoshi Miyata3, and Hiroaki
Shimokawa1,2,3
1Department of Cardiovascular Medicine, Tohoku University
Graduate School of Medicine, Sendai, Japan
2Big Data Medicine Center, Tohoku University, Sendai, Japan
3Department of Evidence-Based Cardiovascular Medicine, Tohoku
University Graduate School of Medicine, Sendai, Japan
Background: Prognostic impacts of serum uric acid (SUA)
levels in patients with heart failure (HF) still remain unclear.
We examined the relationship between SUA levels and the
prognosis of patients with chronic HF (CHF) with a special
reference to sex. Methods and Results: We classified 4652
consecutive CHF patients registered in our Chronic Heart Fail-
ure Registry and Analysis in the Tohoku District-2 (CHART-2)
Study (N ¼ 10 219) into 4 groups based on their baseline SUA
levels by the Classification and Regression Tree; G1 (<3.8 mg/
dL), G2 (3.8 to 7.1 mg/dL), G3 (7.2 to 9.2 mg/dL), and G4
(>9.2 mg/dL). In G1, G2, G3, and G4, mean age was 71 + 12,
68 + 11, 66 + 13, and 67 + 16 years in males, and 71 + 13,
71 + 12, 73 + 12, and 77 + 9 years in females, respectively
(both P < .001). Figure 1 shows the incidence rates during the
median 6.3-year follow-up and hazard ratios for death and HF
hospitalization in each group. Univariable Cox proportional
hazards models showed the U-shaped relationship between
SUA levels and prognosis in males, while not in females
(P value for interaction 0.049 for all-cause death and 0.045 for
HF admission); compared with G2 (reference), G1, G3, and G4
had significantly increased risks for all-cause death and HF
admission in males, while G3 and G4, but not G1, did so in
females. However, in multivariable Cox models with clinically
important covariates, both males and females had the U-shaped
relationship between SUA levels and prognosis (P value for
interaction 0.541 for all-cause death and 0.445 for HF
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admission). Conclusions: Sex difference exists in the relation-
ship between SUA levels and prognosis in CHF patients, which
was mainly attributable to the difference in G1. It is important
to note that low SUA level is predictive of worse prognosis in
males, but not in females, in the secondary prevention setting of
CHF patients.
Daylight Saving Time and Circulatory
Deaths: Are There Differences By Sex? Data
From the Veneto Region of Italy
Roberto Manfredini1, Rosaria Cappadona1, Ruana
Tiseo1, Fabio Fabbian1, Alfredo De Giorgi1, Giulia
Capodaglio2, and Ugo Fedeli2
1Faculty of Medicine, Pharmacy and Prevention, University of
Ferrara, Italy
2Epidemiological Department, Veneto region, Padua, Italy
Some years ago, a study by the Karolinska Institutet first
reported an association between daylight saving time transi-
tions and an increased frequency of acute myocardial infarction
(AMI) after the spring shift, and the effect was somewhat more
pronounced in women than in men. A recent meta-analysis by
our group, based on the available further studies, did not find
differences by sex. We aimed to verify this observation in
Veneto, a large region of North-Eastern Italy, with a total pop-
ulation of about 4 900 000 inhabitants. We performed a retro-
spective analysis on the regional archive of mortality records,
years 2000 to 2015. For death classification, we utilized the
ICD-9 and ICD-10 categories used in standard reports of mor-
tality statistics. The number of deaths observed in each of the 7
days after the spring and the autumn shift (posttransitional
weeks) was compared with the mean number of deaths regis-
tered in the corresponding week-day of the 2 weeks before and
the 2 weeks after the posttransitional week (reference period).
During the study period, a total of 10 387 circulatory deaths
were registered in the Spring and Autumn posttransitional
weeks. No overall excess mortality was found in the posttransi-
tional weeks with respect to the reference period in both Spring
and Autumn. When analyzing the day-of-week pattern of mor-
tality on total population, although a statistically significant
excess of deaths (P ¼ .011) was observed on Tuesday only
after the Spring post-transitional week, no differences by sub-
groups by sex were found. This study provides further confir-
mation of the existence of a modest, but significant, excess of
death on the first days of the week, only after the Spring shift
but with no differences by sex subgroups. It is likely that phase
advance, sleep deprivation, and disruption of circadian rhythms
could play some role, but these mechanisms need further
investigation.
Gender Differences of an Impact of Variant
Mitochondrial Dehydrogenase Type2
Genotype in Patients With ST-Elevated
Myocardial Infarction
Toshifumi Ishida1, Yuji Mizuno2, Yuichiro Arima1, Eisaku
Harada2, Takayoshi Yamashita1, Koichiro Fujisue1, Seiji
Takashio1, Eiichiro Yamamoto1, Satoru Suzuki1, Kenji
Sakamoto1, Koichi Kaikita1, Kentaro Oniki3, Junji
Saruwatari3, Seiji Hokimoto4, Hirofumi Yasue2, and
Kenichi Tsujita1
1Department of Cardiovascular Medicine, Faculty of Life Science,
Graduate School of Medical Sciences, Kumamoto University, Japan
2Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital,
Kumamoto Aging Research Institute, Japan
3Division of Pharmacology and Therapeutics, Graduate School of
Pharmaceutical Sciences, Kumamoto University, Japan
Figure 1. Prognostic impacts of serum uric acid levels (Cox proportional hazard model).
18 Gender and the Genome
4Division of Cardiovascular Medicine, Kumamoto City Ueki Hospital,
Japan
Background: Mitochondrial aldehyde dehydrogenase type 2
(ALDH2) removes toxic aldehydes, generated and released on
ischemia/reperfusion injury (IRI). The deficient variant geno-
type (ALDH2*2) is prevalent among East Asians and the allele
is randomized at conception (Mendelian randomization). It is
unknown whether the ALDH2*2 is associated with the severity
of IRI in ST-segment elevation myocardial infarction (STEMI)
patients. Hypothesis: The IRI is exacerbated in STEMI
patients with variant the ALDH2*2 compared to wild
ALDH2*1/*1. Methods and Results: The study subjects com-
prised consecutive 219 (167 men and 52 women) Japanese
STEMI patients who underwent successful primary percuta-
neous coronary intervention (PCI) within 12 hours after onset.
Of the study patients, 112 (51.1%) carried variant ALDH2*2
and the remaining 107 (48.9%) wild ALDH2*1/*1. There were
no differences in clinical features between the ALDH2*2 and
ALDH2*1/*1 group except lower alcohol habit (14.7 vs 54.4%,
P < .001) in the ALDH2*2 group. However, the peak plasma
levels of creatine phosphokinase (CK) and creatine phospho-
kinase isoenzyme muscle/brain (CK-MB) were significantly
higher in the ALDH2*2 than ALDH2*1/*1 group (2186 vs
1610 U/L, P ¼ .001 and 208 vs 147 U/L, P ¼ .036, respec-
tively). Further analysis revealed that peak CK and CK-MB
were more significantly elevated (2455 vs 1595 U/L, P <
.001, 222 vs 146 U/L, P ¼ .004, ALDH2*2 and ALDH2*1/*1
group, respectively) in males but not in females (1482 vs 1705
U/L, P ¼ .949, 152 vs 171 U/L, P ¼ .6, ALDH2*2 and
ALDH2*1/*1 group, respectively). Multivariable logistic
regression analysis revealed that ALDH2*2, and ALDH2*2
plus males were significant risk factor for severe IRI (OR ¼
2.13; P ¼ .012; OR ¼ 3.05; P < .001, respectively). Conclu-
sions: The peak CK and CK-MB were significantly elevated in
the ALDH2*2 compared with ALDH2*1/*1 STEMI patients
preferentially in males. The deficient ALDH2 activity therefore
exacerbates IRI in STEMI patients.
Relationship Between Uric Acid, Renal
Dysfunction, and Left Ventricular
Remodeling in Hypertensive Women
Akiko Yoshikawa, MD1, Shuichi Hamasaki, MD2, Satoko
Ojima, MD1, and Mitsuru Oishi, MD1
1Department of Cardiovascular Medicine and Hypertension,
Graduate School of Medicine and Dental Sciences, Kagoshima
University, Kagoshima, Japan
2Department of Cardiology, Kagoshima City Hospital, Kagoshima,
Japan
Background: Left ventricular (LV) hypertrophy is a strong
predictor of cardiovascular mortality in women, and, in partic-
ular, concentric hypertrophy is associated with poor prognosis
in hypertensive patients. The aim of this study was to elucidate
the gender difference in the relationship between CKD, UA,
and LV geometry patterns. Methods and Results: A total of
682 (461 men, 221 women) consecutive patients with essential
hypertension were evaluated using echocardiography. We
investigated the relationship between estimated glomerular fil-
tration rate and UA with LV hypertrophy according to the 4
different patterns of LV geometry: normal geometry, con-
centric remodeling, eccentric hypertrophy, and concentric
hypertrophy. Concentric hypertrophy was present in 151
(68%) hypertensive women and in 230 (50%) hypertensive
men (P < .001). Estimated glomerular filtration rate was lower
in hypertensive women with concentric hypertrophy than in in
hypertensive women with normal geometry (60.7 vs 79.7 mL/
min/1.73 m2; P < .05). UA was higher in hypertensive women
with concentric hypertrophy than in hypertensive women with
normal geometry (5.6 vs 4.1 mg/dL; P < .05). In patients with
concentric hypertrophy, LV mass index inversely correlated
with eGFR and positively correlated with UA in women (r ¼
0.20, P ¼ .016; r ¼ .44, P < .0001, respectively) but not in
men. Conclusions: Concentric hypertrophy was significantly
more prevalent in hypertensive women than in hypertensive
men. Furthermore, renal function and UA were associated with
LV hypertrophy in hypertensive women with concentric
hypertrophy.
Sex Differences and Real World Registry in a
Cryptogenic Ischemic Stroke via Patent
Foramen Ovale
Shigefumi Fukui1, Shunsuke Tatebe1, Ryo Konno1,
Yosuke Terui1, Haruka Satoh1, Saori Yamamoto1,
Kotaro Nochioka1, Kimio Satoh1, Koichiro Sugimura1,
and Hiroaki Shimokawa1
1Department of Cardiovascular Medicine, Tohoku University
Hospital, 1-1 Seiryo-machi, Aoba-ku, Japan
It was shown as robust evidence in a multicentre, randomized,
open-label trial that device closure of a patent foramen ovale
(PFO) significantly reduces recurrent ischemic strokes com-
pared to medical therapy alone. Therefore, it is expected that
the specified PFO occluder will be soon reimbursed also in
Japan following the United States. In addition, a recent meta-
analysis of those randomised controlled trials revealed that
device closure was more beneficial in men, implying the sex
differences in a cryptogenic ischemic stroke via PFO. How-
ever, the Risk of Paradoxical Embolism (RoPE) score, which
currently guides the decision of which patients benefit from
PFO closure, includes only age, hypertension, diabetes, a his-
tory of stroke, smoking, and type of stroke, but not sex. On the
other hand, we have shown in the Chronic Heart Failure Anal-
ysis and Registry in the Tohoku District-2 Study that 19.4% of
the patients with stage C/D chronic heart failure complicated
stroke at baseline. However, the systematic collaboration by
stroke specialists and cardiologists has been absent in our hos-
pital, in evaluating the etiology, demographics, and treatment
options of stroke associated with heart disease. Recently, we
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have established the Brain-Heart Team with the stroke special-
ists in our hospital. Now, we are planning to expand our Brain-
Heart Team to the high volume centres of strokes in the whole
Tohoku District, to establish multicenter, real world registry of
a cryptogenic ischemic stroke. In this session, we would like to
discuss the impact of the sex differences in a cryptogenic
ischemic stroke and PFO closure by introducing our real world
registry.
Capillaroscopic Alterations in the
Phenomenon of Raynaud in Men and Women
Sirufo MM, De Martinis M, Ginaldi L1
1Department of Life, Health and Environmental Sciences, University
of L’Aquila; Allergy and Clinical Immunology Unit, AUSL 04 Teramo,
Italy
Raynaud phenomenon (RP) is a pathological condition of
vasospasm in response to cold or emotional stimulation, affect-
ing the extremities, mainly the fingers. Clinically, it is charac-
terized by 3 successive phases: the white (ischemic) phase, the
cyanotic (deoxygenation) phase, and the red (reperfusion)
phase. Raynaud phenomenon is often secondary to autoim-
mune diseases, exhibiting typical microvascular alterations.
In the absence of diseases able to cause it, RP is called primi-
tive (PRP). Primitive Raynaud phenomenon is present in 5% to
20% of women and 4% to 14% of men, and due to its clear
prevalence in women it is traditionally considered a gender
pathology. The naifold videocapillaroscopy (NVC) is an in
vivo noninvasive instrumental technique easily repeatable,
which allows to study in real time the morphological and func-
tional characteristics of microcirculation. The purpose of our
study is to verify whether there are gender specific capillaro-
scopic alterations in patients having PRP. We evaluated 434
subjects affected by PRP, observed in the last year at the out-
patient NVC service of our Allergology and Clinical Immunol-
ogy division. Three hundred-thirty were females (mean age 45
years + 6,1 DS) and 96 were males (48 + 4,3 years DS).
Patients affected by autoimmune pathologies, as well as smo-
kers or those with a history of exposure to ionizing radiation or
chemicals capable of inducing a secondary RP, were excluded
from the study. No significant gender differences were found in
the NVC patterns observed: 148 (43.7%) females and 46
(47.91%) males had a normal NVC pattern (high skin transpar-
ency, absence of morphological abnormalities, uniformity of
diameter and distribution of the capillaries, hairpin capillaries
arranged in a parallel fashion to each other), whereas 190
(56.21%) females and 50 (52.08%) males exhibited an abnor-
mal nonspecific NVC pattern (microvascular abnormalities
without findings suggestive of scleroderma, and characterized
by lack of morphological homogeneity of capillaries, presence
of tortuous capillaries, ectasia of the efferent tract of the loops).
The PRP, even though it is a patology that affects the females
more than men, doesn’t exhibit gender-related differences in
the characteristics and distribution of capillaroscopic patterns.
Human Induced Pluripotent Stem Cells as
Alternatives to Animal Models For Studying
Sex Differences
Judith Lechner1, Georg Kern1, Elisabeth Feifel1, Anja
Wilmes2, Paul Jennings2, and Gerhard Gstraunthaler1
1Div. Physiology, Medical University of Innsbruck, Innsbruck, Austria
2Molecular and Computational Toxicology, Faculty of Science, Vrije
Universiteit Amsterdam, Amsterdam, the Netherlands
Sex and sex hormones affect all the cells in the body resulting
in different susceptibility to cellular stressors and disease
development. Researchers engaged in basic research and pre-
clinical studies are increasingly challenged by regulatory bod-
ies, major funding agencies, and highly ranked journals to also
include sex as a biological variable into their study designs. At
present, these requirements are mostly met—if at all—through
animal experimentation. Besides concerns about how well the
human system is represented by animals, there is also an ethical
problem. This is addressed by regulations to promote the prin-
ciples of refinement, reduction, and replacement (3Rs) of ani-
mal experimentations (eg, Directive 2010/63/EU). Great
efforts are addressed worldwide to the development of alterna-
tive methods to animal testing. However, in vitro models for
researching and testing of sex differences are not in the focus.
Human induced pluripotent stem cells (hiPSC) generated from
human somatic cells present a new trajectory to develop novel
and ethically acceptable in vitro model systems for studying
sex differences. The cells can be differentiated into any cell
type of the body. Cell culture conditions during reprogram-
ming, stem cell propagation and differentiation need to be
adapted in order to establish valid models for researching sex
as a biological variable in vitro using hiPSC. We have devel-
oped a differentiation protocol for renal proximal tubular like
cells from hiPSC. Currently, we work on refining the model to
allow studying sex differences. For this purpose, hiPSCs
derived from males and females are treated with different com-
binations of sex hormones during the differentiation process.
Human induced pluripotent stem cells-derived models are
expected to provide improved preclinical data avoiding prob-
lems arising from species differences between animals and
humans and allowing to account for the genetic variability
among the human population and sex differences.
“Effect of Gender on Hypoglycemia’s Risk
and Worse Clinical Outcome Among
Diabetic Patients Admitted to Internal
Medicine Departments.”
Elena Barbagelata1, FlavioTangianu2, Imma Ambrosino3,
Tiziana Ciarambino4, Cecila Politi5, and “F.A.D.O.I.
Giovani Group”
1UOC Medicina Interna, ASL 4 Chiavarese, Genova, Italy
20 Gender and the Genome
2UOC Medicina Interna, ASST Settelaghi, Ospedale Luini
Confalonieri, Luino, Italy
3Geriatria, ASL Ba DSS 13, Bari, Italy
4UOC Medicina Interna, ASL Caserta, Ospedale Clinicizzato di
Marcianise, Caserta, Italy
5UOC Medicina Interna, P.O.“F. Veneziale”, Isernia, Italy
Background: The incidence of hypoglycemia is high in type 2
diabetes mellitus (T2DM) patients who use insulin or hypogly-
cemic agents. Documented hypoglycemia is associated with
poor prognosis among patients admitted to internal medicine
departments. Marked gender differences in glucose control
have been observed in several studies, however, the influence
of gender on the frequency and impact of hypoglycemia in
hospitalized patients with diabetes is not completely known.
Previous studies have suggested that females with T2D are less
likely to reach glycemic targets and have a higher risk of hypo-
glycemia with insulin therapy compared to males, suggesting
that gender may play a role. Aims: We will conduct a not profit
multicentric retrospective protocol study of a pylot trial. To
investigate the effect of gender on hypoglycemia’s risk among
patients with T2DM in antihyperglycemic therapy admitted to
Internal Medicine Units and to evaluate the association of
hypoglycemia with worse clinical outcome. Methods: We will
collect the electronic medical records of 500 patients with
T2DM from 12 Internal Medicine Departments across Itlay
between January 2019 and April 2019. Data extracted will
include all glucose measurements, glycated haemoglobin A1c
values, estimated glomerular filtration rate values, clinical and
demographic data, Charlson comorbidity index, insulin regi-
men or hypoglycemic agents, and incidence of complications
during admission will also be collected. Regression analysis
will be used to assess the association between documented
hypoglycemia and age, sex, length of hospital stay, inhospital
mortality. Conclusions: Women with T2DM have poorer gly-
cemic control than men, probably because of differences in
glucose homeostasis, treatment response, and hypoglycemia’s
risk. Development and implementation of more gender-
sensitive clinical approach and sex-specific treatment guide-
lines may help to reduce development of complications, such
as hypoglycemia, may improve quality of life and increase
health and life expectancy in men and women with type 2
diabetes.
Sex and Gender in Complex Systems
Peter Klimek1,2
1Section for Science of Complex Systems, CeMSIIS, Medical
University of Vienna, Vienna, Austria
2Complexity Science Hub Vienna, Vienna, Austria
With the accumulation of large amounts of data, a new predic-
tive, personalized and data-driven approach to medicine has
emerged. It has become clear that most chronic disorders
emerge from concerted interactions of multiple genetic, meta-
bolic, social, or lifestyle-related risk factors. In this talk, we
will demonstrate how the theory of Complex Systems offers a
novel methodological toolkit to understand how these different
factors and their interactions impact patient health in a sex- and
gender-specific way. Heterogeneous health-related data sets
can often be quantified by means of networks that record indi-
vidual risk factors (from molecular to societal levels) and their
interactions in different diseases. For instance, we will show
how males and female build their social networks in different
ways and how the structure of these networks determines their
susceptibility to disorders such as obesity or depression. Using
administrative data from an entire country over several years,
we find that males and females show highly distinctive patterns
in the way in which their health typically changes over the
course of their life which allows the identification of
“typical male or female”-associated longitudinal disease tra-
jectories. Furthermore, we show how network approaches
can be used to gain insight into sex-specific adverse drug
events and the extend to which males and females differ in
their health-care utilization. In conclusion, sex and gender
shows highly complex interactions with other disease risk
factors across multiple domains, ranging from the very
small (molecular level) to the very big (institutional config-
uration of the healthcare system). Novel methodological
approaches are needed for a more stringent consideration
of gender differences in (chronic) diseases and to contribute
to better targeted prevention, more patient-oriented and
more efficient therapeutic approaches.
Sex and Gender Differences in
Antihyperglycemic Treatment
Alexandra Kautzky-Willer1,2
1Clinical Division of Endocrinology and Metabolism, Gender
Medicine Unit, Department of Internal Medicine III, Medical
University of Vienna, Vienna, Austria
2Gender Medicine Institute, Gars am Kamp, Austria
Type 2 diabetes mellitus and associated complications are an
increasing problem worldwide in both sexes and go along with
reduced quality of life and life expectancy. Therefore, optimal
therapy is essential and should consider biological factors
including age and sex as well as psychosocial factors and gen-
der issues. However up to now sex and gender have no impact
in most clinical guidelines and decisions. Nevertheless side
effects of drugs as well as choices and preferences of and
adherence to therapies differ between men and women. Gender
sensitive programs to promote healthy lifestyle should be
accompanied by personalized pharmacological therapy consid-
ering complications, sexual function, individual expectations
and fears, and social environment. Antihyperglycemic drugs
differ in regard to their risk of cardiorenal complications, hypo-
glycemia, effects on weight and possibly associations to risk of
fractures and certain cancers. Metformin is the first choice for
both men and women and appears to be particularly effective in
women with previous gestational diabetes and obese men and
women. Overall women have higher risk of hypoglycemia on
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insulin therapy. However, normal weight appears to relate to
higher risk of hypoglycemia in both sexes on basal insulin
therapies. Due to higher risk of stigmatization of obese women,
weight loss is even more important for women, favouring
SGLT2 inhibitors or GLP-1 analogues; thus GLP-1 analogues
were more often prescribed to obese women than men. SGLT2
inhibitors reduce cardiovascular events and hospitalizations
due to heart failure and progression of renal disease in both
sexes. However they are associated with a higher risk of uro-
genital infections and ketoacidosis in women compared to men.
Pioglitazone associates with increased risk of bone fractures,
particularly in postmenopausal women. During pregnancy,
insulin is still the first choice therapy. Overall women seem
to have lower success of antihyperglycemic therapies despite
having more from drug side effects. Most clinical studies still
include more men than women and do not stratify data analysis
by sex. Taking into account sex and gender in diabetes man-
agement could contribute to more personalized better care in
the future.
Sex Differences in the Cardiovascular
Consequences of Type 2 Diabetes
Judith G. Regensteiner, PhD1
1Judith and Joseph Wagner Chair in Women’s Health Research,
Center for Women’s Health Research, Office of Women in
Medicine and Science, Aurora, CO, USA
By 2017 estimates, diabetes mellitus affects 425 million peo-
ple—approximately 90% to 95% have type 2 diabetes and the
number is rising. The cardiovascular (CV) consequences of
type 2 diabetes are overall worse in women than men across
the life span. These disparities include: (1) increased CV mor-
tality, (2) increased CV morbidity, and (3) lower rates of CV
risk factor control. These sex differences appear partly related
to biological factors, though there are also disparities in provi-
der level prescribing patterns and patient-level adherence pat-
terns. This talk will take a life span approach to describing
these sex differences in CV outcomes, starting with children
exposed to gestational diabetes in utero, and including those
diagnosed with type 2 diabetes during youth, in midlife, and in
later life, respectively. The major goal of this talk is to highlight
research gaps that must be addressed to better understand how
to potentially redress these sex differences. I also will summar-
ize clinical opportunities to improve these disparities.
Stroke and Dementia (Invited Speech)
Mia von Euler, MD, PhD1, Zupanic E1, Garcia-Ptacek S
Kåreholt I1, Religa D1, Kramberger MG1, Norrving B1,
Winblad B1, Eriksdotter M1, and Von Euler M1
1Neurology Karolinska Institutet, Stockholm, Sweden
Stroke and dementia are common causes of death and acquired
functional disability for both men and women. For ischemic
stroke and intracerebral hemorrhages, the incidence is higher in
men up to the age of 85 years when it becomes more common
in women. For subarachnoidal bleeding the incidence is higher
in women. Stroke can lead to cognitive impairment and demen-
tia itself is associated with a 3 to 7 fold higher risk of stroke.
Although the risk factors for stroke and dementia are similar in
men and women, the impact may vary. Effect of acute reperfu-
sion treatment and pharmacological prevention seems similar
between men and women but access to treatment has shown
varied results. In a registry-based longitudinal cohort study on
differences between men and women with ischemic stroke with
and without prestroke dementia, we compared reperfusion
treatment and outcomes. Using data from the Swedish Demen-
tia and Stroke Registries 2010 to 2014, we identified patients
with dementia and acute ischemic stroke (765 women, 592
men) and compared them with matched nondementia subjects
(3838 women, 2917 men) regarding reperfusion treatment and
outcomes at 3 months (death, residency and modified Rankin
Scale score [mRS]). Of those surviving hospitalization, more
women than men with dementia had a poor outcome, had insti-
tutional care or home help (P < .001). When adjusting for age,
dementia, and stroke severity (determined by level of con-
sciousness) odds ratio was higher for women for a poor out-
come, mRS 3-6, at 3 months (odds ratio [OR]: 1.60, 95%
confidence interval [CI]: 1.42-1.81), lower for death 1 year
after stroke (OR: 0.876, 95% CI: 0.78-0.98), and higher for
higher level of assisted living (OR: 1.30, 95% CI: 1.15-1.47).
For death 1 year after stroke, there was no difference between
men and women if dementia was not included in the analysis
while worse living conditions and poor functional level
remained in women.
Carotid Surgery in Men and Women
Rebecka Hultgren1
1Patientområde Kärlsjukdomar, Fd. Kärlkirurgiska Kliniken,
Karolinska Universitetssjukhuset, Stockholm Aneurysm Research
Group, STAR, MMK, Karolinska Institutet, Stockholm, Sverige
Strong evidence based on multicenter RCTs support the ben-
efit of vascular interventions in selected patients with signif-
icant stenosis of their internal carotid artery in order to
decrease the risk of a subsequent fatal neurological event. The
indication of surgical treatment should be correlated to the
degree of stenosis, which have rendered debate, but consensus
is that intervention should not be performed in men or women
below 50%. However, as for all surgical procedures other
factors strongly contribute in the preoperative work-up eva-
luation, and influences eligibility, such as age, ongoing med-
ication, morphology of arteries. The selection for patients
actually subjected to be evaluated for a vascular intervention
does influence the possibility to in-depth analyze relevant
sex-and gender differences. The presentation will cover the
most recent reported findings in the field in vascular treatment
for carotid stenosis, endovascular and open, and also present
contemporary outcome data.
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Arrhythmias in Women and Men
Karin Schenck-Gustafsson1
1Karolinska Institutet and Karolinska University Hospital, Stockholm,
Sweden
Recent research has revealed sex-difference in the appear-
ance of rhythm disturbances as well as differences in the
pathophysiology, symptoms, and treatment. Atrial fibrilla-
tion especially in elderly women, increases the risk of stroke
as well as death and cardiovascular outcomes more in
women than in men. Women have also been undertreated
both with invasive treatment like ablation as well as with
drug treatment. Atrial fibrillation is the most common sus-
tained arrhythmia in adults and carries a risk of significant
morbidity and mortality, especially an increased risk of
stroke. Many of these patients experience palpitations, how-
ever not all of them. Also other treatable arrhythmias like
supraventricular tachycardias for example atrio-nodal reen-
try tachycardia might induce palpitations and are important
to detect as well as malignant ventricular arrhythmias. Inde-
pendant of etiology, heart palpitations can cause anxiety,
worry, depression, reduced quality of life, and more so in
women than in men. Atrial fibrillation is uncommon below
the age of 50 years but the prevalence increases by age and
in ages older than 85 years it could be as high as 25% to
30%. It is well-known that women have more symptoms
than men of palpitations and also of anxiety disorders and
poorer quality of life. Studies also indicate sex-difference in
adverse drug reactions like antiarrhythmic drugs, for exam-
ple, women being more sensitive to long QT prolonging
drugs. The aim of the on-going Swedish study Red Heart
is to evaluate if instant analysis and feed back of underlying
heart rhythm during palpitations reduces symptoms, anxiety,
depression, and increases the quality of life. We informed
about the study in connection with our yearly women’s
heart campaign in 20 cities. Recruitment also took place via
social websites. For the first time we used a new form of
eAuthentication via BankID when getting the informed con-
sent of the study from the participants. During the first
weeks in May 2018, totally, 2387 women reported interest
to participate. Of these, the first 1132 were invited and
finally 913 were included. The women who completed the
study were between 21 and 88 years. Coala Heart Monitor
was used by the participants and thumb and chest electro-
encephalography were recorded twice a day and at symp-
toms during 60 days. The system uses a well-validated
algorithm to analyze heart rhythm and is connected to the
user’s smartphone and provides immediate response to the
user. Questionnaires addressing symptoms like anxiety,
depression, HRQOL were analyzed before and after the
study period. In the great majority of episodes causing
symptomatic palpitation in women, the underlying arrhyth-
mia was benign. However, in 5% previously undiagnosed
atrial fibrillation or supraventricular tachycardia were found.
These women were referred to a doctor. Among the
participating women, 75% had palpitations more than once
a week, 66% had contacted a doctor because of the symp-
toms. Notably 40% of the women experienced that they
were not taken seriously by the health-care system when
they seek help. Much more information will come out from
our study and in the follow-up we will also include men. In
total over 280 000 registrations were monitored making this
study probably the largest arrhythmia study in women in the
world.
Sexual Function, Gender Role, and Sexual
Preference in Females with Classical Versus
Nonclassical Congenital Adrenal Hyperplasia
Marie-Helene Schernthaner-Reiter1#, Sabina
Baumgartner-Parzer1#, Hans Christian Egarter2, Kathrin
Kirchheiner3, Michael Krebs1, Alexandra Kautzky-
Willer1, Anton Luger1, Michaela Bayerle-Eder1
1Clin. Div. of Endocrinology and Metabolism, Dept. Internal
Medicine III, Medical University of Vienna, Vienna, Austria
2Clin. Div. of Gynecologic Endocrinology and Reproductive Medicine,
Dept. of Obstetrics and Gynecology, Medical University of Vienna,
Vienna, Austria
3Dept. of Radiotherapy, Medical University of Vienna, Vienna, Austria
Congenital adrenal hyperplasia (CAH) due to 21-
hydroxylase deficiency is an autosomal recessive disease
caused by mutations in the CYP21A2-gene. The severity
of the mutations is mirrored by a wide spectrum of different
biochemical (hyperandrogenism, hypocortisolism) and phe-
notypic (virilization, hirsutism) symptoms. The present
cross-sectional cohort analysis aimed to evaluate sexual
function, gender identification, and partner preference in
classic (C-CAH) versus nonclassic CAH (NC-CAH).
Depending on their pheno- and genotype (determined by
Sanger sequencing and MLPA), 35 female patients with
CAH were divided into 2 groups: classic CAH (severe defi-
ciency, salt-wasting or simple virilizing, n ¼ 17) and NC-
CAH (n ¼ 18). Sexual function and sexual distress, gender
role and sexual satisfaction were assessed using established
questionnaires (FSFI, FSDS, BSRI) and visual analogue
scales. Phenotype (as defined by signs of hyperandrogen-
ism) was assessed clinically (Ferriman-Gallwey score) as
well as with the ovulatory function index. Moreover, sexual
function was separately analyzed in the context of clinical
signs of androgenization in women with (n ¼ 13) and without
acne (n ¼ 22). Women with NC-CAH had significantly lower
orgasm scores, a trend toward lower sexual function with
higher sexual distress and biochemical evidence of hyperan-
drogenism (higher DHEA-S, lower SHBG). Presence of acne
in all patients was related to lower sexual function and higher
sexual distress. These findings stress the importance of early
diagnosis and therapy initiation particularly in patients with
NC-CAH.
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Cardiometabolic Effects of Cross Sex
Hormone Therapy in Transgender Patients
Lana Kosi Trebotic, MD1, Carola Deischinger, MD1,
Anita Thomas, BSc1, Ivica Just-Kukurova, PhD2, Siegfried
Trattnig, MD2, Ulrike Kaufmann, MD3, and Alexandra
Kautzky-Willer, MD1
1Division of Endocrinology and Metabolism, Department of Internal
Medicine III, Gender Medicine Unit, Medical University of Vienna,
Vienna, Austria
2Centre of Excellence, High-Field MR, Department of
Radiodiagnostics, Medical University of Vienna, Vienna, Austria
3Department for Obstetrics and Gynaecology, Medical University of
Vienna, Vienna Austria
3Siemens AG Healthcare, Vienna, Austria
Background: Sex hormones are believed to play an important
role in development and progression of cardiovascular disease.
However, the gender gap in onset and mortality is not yet
completely understood. Transsexuals undergoing hormone
therapy are a promising collective for analysing the effects
of sex hormones on cardiometabolic disease. Methods: Aim
of this study is to identify gender specific cardiovascular
changes attributed to high-dose hormone therapy in male-to-
female (MtF) and female-to-male (FtM) transgender patients
by performing an oral glucose tolerance test and 3T magnet
resonance spectroscopy for hepatic (HCL) and myocardial
lipid content analysis. Results: Until now we included 15 MtF
and 10 FtM patients. The mean age was comparable in both
populations (MtF 31.12 + 2.31 vs 29.72 + 1.91 as well as
body mass index [23.59 + 3.81 vs 21.62 + 2.53 kg/m2). The
mean hormone therapy duration was similar in both groups
(MtF 4.58 + 1.20 vs FtM 2.35 + 0.95, P ¼ 0.29). HOMA
index did not significantly differ between the groups (MtF
1.78 + 0.92 vs FtM 1.96 + 1.22). Hepatic lipid content was
significantly higher in MtF than FtM (1.50% + 0.41% vs
0.54% + 0.33%, P ¼ .022, respectively). We also found a
significant correlation between ejection fraction and testos-
terone levels in FtM only (Spearmans Rho 0.80, P ¼ .002).
Conclusion: These preliminary data could indicate a positive
effect of testosterone therapy in FtM on heart function. Con-
tradictory to current data, we found a higher HCL in MtF than
FtM suggesting a not so protective estrogen effect when look-
ing at the liver. Long-term studies are warranted to assess
whether cross sex HT results in different outcomes regarding
cardiovascular disease.
The Contribution of the Italian National
Institute of Health on Transgender Health
Marina Pierdominici1, Matteo Marconi1, Maria Luisa
Dupuis1, Luciana Giordani1, Carmela Santangelo1,
Angela Ruocco2, Maria Teresa Pagano1, Paola
Matarrese1, and Walter Malorni1, Alessandra Carè1
1Center for Gender Specific Medicine, Istituto Superiore di Sanità,
Rome, Italy
2National Center for Rare Diseases, Istituto Superiore di Sanità,
Rome, Italy
Email marina.pierdominici@iss.it
Transgender people are a medically underserved population in
both primary and specialist care settings. Moreover, despite the
growing interest of the scientific community in transgender
health, this subject remains understudied. Unavailability of
realistic estimates of transgender prevalence, limited data on
general health status and the long-term effects of gender
affirming hormone treatment and surgical interventions are
among the main problems to be solved in terms of transgender
health research. Nowadays, in Italy, as across much of the
world, we do not know exactly how many transgender people
there are, their health status and the services they need. This
hinders a suitable health planning by policy makers and an
appropriate activity by the Italian National Institute of Health
(NIH). Additionally, given the probable size of transgender
population (at least 500 000 people) and the large range of
health-care needs, it is crucial that health-care providers could
be trained in transgender health care. It is urgently warranted to
fill all these gaps to provide an appropriate evidence-based
prevention and care for people. To this aim, the Center of
Gender Specific Medicine at the Italian NIH is creating a close
network of collaborations among public health institutes, pol-
icy makers, health-care providers, and transgender commu-
nities. Different projects including research, medical training
with specific courses, and communication campaigns directed
to citizens have been performed and launched. Two studies
aimed at evaluating the size of transgender people and their
health status, respectively, are undergoing. We consider of
great relevance the part of our project dealing with communi-
cation/information of the citizens with the creation of the first
institutional web site on legal and health information dedicated
to the transgender population. These activities could represent
a first step toward a more inclusive health policy aimed at
improving the interplay between transgender people and the
health-care system.
Making Sense of Sex Differences in the Brain;
a Whole-Body Approach
Geert J. de Vries1
1Neuroscience Institute and Department of Biology, Georgia State
University, Atlanta, GA 30303, USA
This presentation will play with three interrelated ideas. First,
there are sex differences in all organs in the body; the brain is
no exception. Second, sex differences in the body forge sex
differences in the brain. Third, sex differences in the brain
serve 2 roles: to prevent as well as to cause sex differences
in behavior and physiology. The consequences of these ideas
for the role of the brain in health and disease will be discussed
using sex differences in vasopressin function as an example.
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Sex Differences in The Molecular Regulation
of Memory: Implications for the Development
of Sex-Specific Treatments for Memory
Dysfunction
Karyn Morrione Frick, PhD1
1Department of Psychology, University of Wisconsin-Milwaukee, WI,
USA
Estrogens play a key role in the etiology and symptomatology
of psychiatric illnesses (eg, depression, anxiety) and neurode-
generative diseases (eg, Alzheimer disease). Thus, understand-
ing exactly how estrogens regulate cognitive and emotional
processes is essential to developing the next generation of ther-
apeutics to treat conditions such as these for which women are
at greater risk. However, estrogens modulate cognitive and
brain function not only in females but also in males, so a
thorough understanding of how estrogens mediate cognition
requires knowledge of the mechanisms through which it acts
in both sexes. Although we have learned much in recent years
about the molecular mechanisms through which estradiol med-
iates memory consolidation in female rodents, considerably
less is known about estrogenic regulation of memory processes
in males. This talk will first summarize my laboratory’s work
in female mice identifying molecular mechanisms in the dorsal
hippocampus necessary for estradiol to enhance memory con-
solidation and promote hippocampal and neocortical dendritic
spine density. Next, our recent work examining how estradiol
regulates memory consolidation in male mice will be
described, including data suggesting significant sex differences
in the cell-signaling mechanisms underlying estradiol-induced
memory enhancement. Finally, the implications of these find-
ings for developing sex-specific treatments for memory dys-
function will be considered.
Women’s Brain Health and Aging
Nicole J. Gervais1 and Gillian Einstein1,2,3
1Department of Psychology, University of Toronto, Toronto, Ontario,
Canada
2Rotman Research Institute, Toronto, Ontario, Canada
3Tema Genus, Linköping University, Linköping, Sweden
Growing evidence implicates ovarian hormones in maintaining
brain health in women as they age. Following menopause, 17b-
estradiol (E2) and progesterone levels decline, and this loss has
an impact on women’s cognition, and brain structure. Such
effects are exacerbated following oophorectomy prior to spon-
taneous menopause, which is associated with accelerated cog-
nitive decline and a 2-fold higher risk of dementia. Reduced
sleep quality and increased sleep-disordered breathing is also
associated with oophorectomy, which can worsen the cognitive
effects of early hormone deprivation. Estradiol-based hormone
therapy maintains cognitive function and in some instances,
sleep quality in menopausal women. However, few studies
have investigated benefits in women with an oophorectomy.
In this presentation, we present our recent work on cognition,
brain structure, and sleep in middle-aged women with a BSO.
Forty-six BRCA 1/2 mutation carriers with a BSO prior to the
age of 51 and 25 age-matched premenopausal controls were
recruited. Participants with a BSO were stratified based on
whether they were currently taking estradiol therapy
(BSOþE2; n ¼ 22) or had no history of hormone therapy use
(BSO; n ¼ 24). Participants completed a neuropsychological
test battery, underwent a high-resolution T2-weighted struc-
tural magnetic resonance imaging scan (3T Siemens Prisma),
and an at-home polysomnography recording for sleep staging
and sleep-disordered breathing analysis. Results revealed that
BSO is associated with lower memory performance, reduced
hippocampal volume and increased sleep fragmentation, but
only among those not taking E2. These findings demonstrate
adverse effects of early hormone loss on sleep and brain health,
which is prevented by E2 use. The importance of these results
to understanding the role of ovarian hormones in promoting
sleep, memory, and brain health as women age will be
discussed.
Cardiac Symptoms and Menstruation:
A Risky period? The Cycle Study I
MM Schreuder1, M Sunamura2, A Maassen van den
Brink3, M Kavousi4, E Boersma4, and JE Roeters van
Lennep1
1Department of Internal Medicine, Erasmus Medical Centre,
Rotterdam, the Netherlands
2Department of Cardiology, Franciscus Gasthuis, Rotterdam, the
Netherlands
3Department of Internal Medicine, Division of Vascular Medicine
and Pharmacology, Erasmus Medical Centre, Rotterdam, the
Netherlands
4Department of Epidemiology, Erasmus Medical Centre, Rotterdam,
the Netherlands
Background: During the menstrual cycle endogenous female
hormones fluctuate. However, the prevalence of menstrual
cycle-related cardiac symptoms remains unclear. We hypothe-
size that premenopausal women show cyclic variation in car-
diac symptoms with more symptoms during the (pre)menstrual
phase when estrogen and progesteron levels are low, compared
to other menstrual cycle phases. Methods: We performed a
prospective cohort study in premenopausal women with self-
reported cardiac complaints. Women with a regular menstrual
cycle were asked to prospectively fill in an electronic diary for
at least 10 weeks to record episodes of cardiac symptoms dur-
ing 2 menstrual cycles. The prevalence of cardiac complaints
was estimated as the mean of the reported cycles. Results:
Until now, 172 (mean age 40.2 + 7.6 years) women partici-
pated in this ongoing study; 118 women reported on one men-
strual cycle, 68 on 2 cycles. Most participants did not use any
contraception (70%), the oral contraceptive pill (1 week hor-
mone free interval per 3 weeks) was used by 8.5% and the
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remaining used other (nonhormonal) contraception. 38% of
women were currently treated by a cardiologist or GP for their
cardiac complaints, whereas 41% were treated in the past. The
majority of women (58%) were using cardiovascular drugs.
During the first day of menstruation 87% of the women
reported palpitations, which reduced to 32% at the end of the
menstruation (day 6). An increase to 56% was seen during
ovulation (day 14) and after a drop in the midluteal phase (day
19) to 28%, the number of complaints increased again in the in
the late luteal phase (day 27) to 56% (Figure 1A). A similar
time trend was seen with respect to angina pectoris (Figure 1B).
Conclusion: Women most often report cardiac symptoms in
the early follicular phase of the menstrual cycle when both
estradiol and progesterone levels are lowest compared to the
other phases.
Gender Differences in The Risk Factors
Associated With Atherosclerosis By Carotid
Intima-Media Thickness, Plaque Score And
Pulse Wave Velocity
Satoko Ojima1, Takuro Kubozono1, Shin Kawasoe1,
Takeko Kawabata1, Masaaki, Miyata1, Hironori
Miyahara2, Shigeho Maenohara2, and Mitsuru Ohishi1
1Department of Cardiovascular Medicine and Hypertension,
Graduate School of Medical and Dental Sciences, Kagoshima
University, Kagoshima, Japan
2JA Kagoshima Kouseiren Medical Health Care Center, Kagoshima,
Japan
Background: Carotid intima-media thickness (IMT), carotid
plaque score (PS), and brachial-ankle pulse wave velocity
(baPWV) are useful atherosclerotic parameters, and these are
evaluating the different aspect of atherosclerosis. The gender-
specific impact on the risk factors for atherosclerosis by these
parameters is unclear. Hypothesis: We hypothesized that there
are gender differences in the risk factors for atherosclerosis eval-
uated by IMT, PS, or baPWV. Methods: We recruited 3888
participants (women 743 and men 3145 participants) who
underwent health checkups. Intima-media thickness and PS were
evaluated by carotid ultrasonography, and baPWV was measured
by an automatic device. We analyzed the association between
IMT, PS, or baPWV and atherosclerotic risk factors such as age,
obesity, smoking history (Smoking), hypertension (HT), dyslipi-
demia (DL) and impaired fasting glucose (IFG). Both women and
men were divided into two groups using a median value of IMT,
PS, or baPWV. Results: We defined high IMT, PS, or baPWV as
>0.75 mm, >2.3 mm or >1530 cm/s, respectively, in women.
Age and HT were common parameters in women which were
significantly associated with IMT, PS, or baPWV in multivariate
logistic regression analysis. Obesity, DL or IFG was an indepen-
dent additional risk factor of IMT, PS, or baPWV, respectively.
On the other hand, in men, we defined high IMT, PS or baPWV as
>0.75 mm,>2.7 mm or>1484 cm/s, respectively. In multivari-
ate logistic regression analysis, age, HT, DL, and IFG were sig-
nificantly associated with IMT, PS or baPWV. Smoking is
significantly associated with high IMT and PS, whereas obesity
was correlated only with IMT. Conclusion: It is suggested that the
risk factors associated with IMT, PS or baPWV differed by gen-
der. In women, only HT is associated with all atherosclerotic
parameters, and the management of blood pressure may lead to
the prevention and progression of atherosclerosis.
Sex Differences in Patients with Non-ST-
Elevation Myocardial Infarction in Japan: A
Report from the Miyagi AMI Registry
Koichi Sato, MD1, Jun Takahashi, MD1, Kiyotaka Hao,
MD1, Yasuhiko Sakata, MD1, and Hiroaki
Shimokawa, MD1
1Department of Cardiovascular Medicine, Tohoku University
Graduate School of Medicine, Sendai, Japan
Background: Acute myocardial infarction (AMI) is classified
into ST-elevation myocardial infarction (STEMI) and non-ST-
elevation myocardial infarction (NSTEMI) with different ini-
tial stratification of diagnosis and treatment. In the present
study, we examined the sex difference in emergency care and






















































Fig. 1B (atypical) Angina 
Pectoris
Figure 1. Percent of Women reporting palpitations or (atypical) Angina Pectoris.
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Methods and Results: The Miyagi AMI Registry Study is a
prospective and observational study where almost all AMI
patients in the Miyagi prefecture (2.35 million populations)
of Japan have been prospectively registered for 40 years since
1979. In the present study, we analyzed a total of 7145 AMI
patients (STEMI/NSTEMI, 5511/1634) enrolled in the registry
from 2011 to 2017. As compared to STEMI patients, NSTEMI
patients were characterized by older age (NSTEMI 70 + 13
years vs STEMI 68 + 13 years, P < .001), higher percentage
of female (NSTEMI 25% vs STEMI 22%, P < .05), and lower
performance rate of percutaneous coronary intervention (PCI;
NSTEMI 78% vs STEMI 90%, P < .001). When dividing by
age, NSTEMI patients had a higher percentage of women than
STEMI patients in the younger age (64 years), whereas no
difference was noted between the two types of MI in the elderly
patients (>65 years). In the NSTEMI patients, female patients
were older, had a lower performance rate of PCI, and had a
higher in-hospital mortality rate as compared to male patients.
Especially in the very young NSTEMI patients aged49 years,
performance rate of PCI was extremely lower in female com-
pared to male (female 52% vs male 80.5%, P < .05) and the
percentage of AMI with nonobstructive coronary arteries was
also significantly higher (female 20.8% vs male 4.5%, P <
.05). Conclusions: These results indicate that NSTEMI devel-
ops more frequently in relatively young women and that its
pathophysiology may be different between the sexes.
Pulmonary Embolism and Gender:
An Observational Study
Tiziana Ciarambino1, Ombretta Para2, Cecilia Politi3,
Orazio Giannico4, and Anna Maria Moretti4
1Department of Internal Medicine, Hospital of Marcianise, ASL
Caserta, Italy
2Department of Experimental and Clinical Medicine, University of
Florence, Florence, Italy
3Department of Internal Medicine, Hospital of Isernia, F. Veneziale,
ASREM, Italy
4President of GISeG, Italian Group of Health and Gender
Introduction: Pulmonary embolism (PE) is a major cause of
mortality, morbidity, and hospitalization in Europe, but few
studies have highlighted sex differences in PE, in particular
with regard to hospitalization, outcomes, treatment, complica-
tion and mortality. Objective: The aim of this study is to ana-
lyze the gender differences in-patient hospitalized with a
principal diagnosis of PE. Methods: This is a retrospective
population-based cohort study. Data for all patients discharged
with a principal diagnosis of Pulmonary Embolism (ICD-9
415.1) by Apulian hospitals between 2010 and 2016 were
retrieved from the National Hospital Discharge Register Data-
base. Result: A total of 4795 patients were discharged with a
principal diagnosis of PE during the inclusion period, the
majority of which were females (F; 2762; 57.6%). Mean age
was significantly higher in F versus male (M; 73.0 vs 67.9, P<
.001). Females showed an higher prevalence of hypertensive
heart disease (41.1% vs 32.9%, P< .001), arrythmia (16.3% vs
13.9%, P ¼ .023), diabetes mellitus (14.8% vs 11.7%, P ¼
.002) and obesity (6.6% vs 3.5%, P < .001) and a lower pre-
valence of chronic obstructive pulmonary disease (10.0% vs
18.0, P < .001), lung failure (11.1% vs 13.7%, P ¼ .006) and
cancer (15.3% vs 22.9%, P< .001) compared to M. The overall
incidence rate (F: 17.4 vs M: 13.8; respectively; AR ¼ þ3.6;
P < .001) and the overall mortality rate (F:1.3 vs M:0.9;
respectively; AR ¼ þ0.3; P < .001) were higher in female
compared to male. The overall case fatality rate was not dif-
ferent between gender (F: 6.4 vs M:6.4; AR ¼ 0.0; P ¼ 0.92).
Conclusion: Findings from our study showed significant sex
disparities for age of hospitalization, comorbidities distribu-
tion, incidence and mortality, but no differences in the fatality
of the disease. Further studies are needed to identify the deter-
minants and consequences of the gender differences in PE.
European Physicians’ Awareness of the
Difference Between Sex and Gender: the
Imagine Survey
Valeria Raparelli, MD, PhD1,2, Marco Proietti, MD3,4,
Ewelina Biskup, MD5,6, and Alberto Maria Marra, MD7,8
1Department of Experimental Medicine, Sapienza University of
Rome, Italy
2Center for Outcomes Research and Evaluation, Research Institute,
McGill University Health Centre, Montreal, Quebec, Canada
3IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan,
Italy
4Department of Internal Medicine and Medical Specialties,
Sapienza-University of Rome, Rome, Italy
5Shanghai University of Medicine and Health Sciences | Shanghai,
PRC
6Cardiovascular Research Institute Basel (CRIB) and Department of
Cardiology, University Hospital Basel, Basel, Switzerland
7IRCCS SDN Research Institute, Naples, Italy
8Centre for Pulmonary Hypertension, Thoraxclinic at Heidelberg
University Hospital, Heidelberg, Germany
Sex and gender shape health status through dynamic interac-
tion, therefore the integration of sex and gender in research and
clinical approach is mandatory and it drives toward a persona-
lized medicine and equality in health care. On this basis, the
European Federation of Internal Medicine built up the Internal
Medicine and Assessment of Gender differences in Europe
(IMAGINE) working group. The first phase of the IMAGINE
framework was conceived to assess the awareness of the Inter-
nal Medicine community on sex and gender dimension in
approaching clinical and research questions. Therefore, among
December 2017 and March 2018, an online short survey was
run among European internists clinicians. Briefly, the first 3
questions aim to assess the knowledge on terminology (sex vs
gender) and the awareness of factors specifically related or not
to sex and gender dimensions. The fourth question explores the
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perceived knowledge on sex and gender differences in major
diseases within the field of internal medicine. The fifth and
sixth questions point out if physicians checked clinical guide-
lines for the presence of recommendations specifically tailored
according to sex and whether they are aware of the low rate of
women’s enrolment in clinical trials. Finally, the seventh ques-
tion is targeted to the identification the high-priority topics for
internal medicine community in terms of knowledge in a sex-
and gender-perspective. Preliminary results of IMAGINE sur-
vey (>1000 participants) will be presented.
Gender Score Construction Based on
Retrospective Data Analysis in the Berlin
Aging Study II (BASE-II)
A. Tauseef Nauman, MPH1,2,3, Nicholas Alexander,
MPH, PD1,2,3, Friederike Kendel5, Johanna Drewelies7,
Gert G. Wagner8, Denis Gerstorf.PD7, Ilja Demuth4,9,
Louise Pilote6,3, Vera Regitz-Zagrosek1,2,3
1Institute for Gender in Medicine, Charité—Universitätsmedizin
Berlin, Germany
2CCR Berlin, Germany
3DZHK (German Centre for Cardiovascular Research), partner site
Berlin, Germany
4Medical Clinic for Endocrinology, Biology of Aging group, Charité—
Universitätsmedizin Berlin, Germany
5Institute of Medical Psychology, Charité—Universitätsmedizin
Berlin, Germany
6Department of Medicine, McGill University, Montreal Canada
7Dept. of Psychology, Humboldt-Universität zu Berlin, Germany
8SocioEconomic Panel at the German Institute for Economic
Research (DIW), Germany
9Berlin-Brandenburg Center for Regenerative Medicine (BCRT),
Charité University Medicine Berlin, Germany
Sex and gender are distinct constructs that require complex
measurement. As intercultural differences may be an important
factor in capturing the construct “gender,” we aimed to re-
construct a gender score (GS) comparable to the index pub-
lished by L Pilote (APS 2015) in a retrospective analysis of the
Berlin Aging Study BASE-II in 2009-2014 for 1869 partici-
pants aged above 60 years. From the psychosocial and gender-
related (identity, roles, relations, institutionalized gender)
variables we selected 13 with focused on data available in more
than 65% of cases. Our approach was divided in 3 steps: GS
development, GS calculation, and GS application. For step 1 all
1869 cases were used and 9 out of 13 selected variables were
identified by PCA and LR that contributed to a GS that sepa-
rated women and men. A correlation analysis of 13 selected
variables was conducted and in any significantly correlated pair
of variables, one of the variables was removed. However, we
retained all the 13 variables. These 13 variables were loaded
onto 6 components in PCA analysis. Any variable, loading
equally high on 2 components was removed at this step. The
13 identified variables from the PCA were used to perform the
logistic regression analysis. Nonsignificant variables were
removed one by one in a descending order of their P value
(.05). The 9 most significant variables for the sex as an out-
come variable were extracted. The coefficients of the final
logistic regression were used to calculate the GS (0-100). The
procedure enabled us to construct a gender score in a retro-
spective manner from available study variables. Gender score
distribution was significantly different between women and
men. In future analyses, we will examine the validity of the
score by linking differences in gender with psychosocial, med-
ical, and cognitive data and by comparison with a prospectively
assessed gender score.
How to Measure Gender? Developing a
Context-Specific Gender Index to Improve
Health Research in Switzerland
Joana Le Boudec1, Joëlle Schwarz1, and Carole Clair1
1Department of Training, Gender and Medicine Unit, Research and
Innovation, Center for Primary Care and Public Health (Unisanté),
University of Lausanne, Switzerland
Introduction: Differences in health outcomes by sex of
patients and health practitioners have been repeatedly shown.
Research has further brought attention on the role of social
gendered position in explaining part of these differences. None-
theless, health research mostly uses the binary sex variable
when measuring the impact of gender on health issues. This
approach is scientifically problematic at different levels. First
social gender is not a mirror of biological sex, and the sex
variable does not include the different dimensions of gender
(identity, social role, relation). Secondly, gender is not a direct
causal factor of health outcomes, and intermediate factors—
economic inequalities for example—influence health, which
are overseen by using biological sex. Thirdly, research often
responds to the gender-analysis requirements by stratifying
results by sex and interpreting observed results, and such a
posteriori interpretation is subject to gender bias. In an attempt
to address these issues, several scholars have worked on the
development of a gender index and stressed on the importance
of strengthening theoretical frameworks of health research in
order to anticipate the effects of sex and/or gender in a priori
hypotheses. Project description: Our project aims to develop a
gender index for the Swiss context, and to test its quality (valid-
ity, reliability, pertinence and acceptability) in different
research projects, such as population based cohorts. Methodol-
ogy: First a literature review on Swiss context will support
choosing gender discriminating items. Their number and perti-
nence will be reduced by primary component analysis. Perti-
nence will be confirmed by correlation to sex. The resulting
gender index will then be used to distribute patients in (non-
binary) categories according to masculine and feminine charac-
teristics. The approach is multidisciplinary including social
sciences, epidemiology, and clinical research experts. Expected
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results: To develop, test and validate a context-specific gender
index, to be used in health research and beyond.
The Going-FWD (Gender Outcomes
International Group: to Further Well-being
Development) Project"
Valeria Raparelli, MD, PhD, Maria Trinidad Herrero,
Elizabeth O. Johnson, Alexandra Kautzky-Willer,
Karolina Kublickiene, Colleen M. Norris, and Louise Pilote
Background: GOING-FWD, is a personalized medicine proj-
ect recently funded by the Canadian Institutes of Health and
Research, in addition to GENDER-NET plus, which is a part of
the European EU H2020 initiative. Psycho-cultural-social fac-
tors, which are associated with the gender of individuals, are
seldom assessed as determinants of health outcomes, despite
their powerful contribution to overall well-being. Gender is a
complex construct which is different from the “biological sex.”
Gender-related factors including gender identity, gender role,
gender relations and institutionalized gender are assumed to
differ between sexes. Objective: To develop a standard meth-
odology that can be applied in retrospective cohort studies for
the integration of gender-related factors in assessing their
impact for cost-sensitive outcomes. Methods: For the
GOING-FWD project, we identified 32 accessible cohorts/
databases that include noncommunicable chronic diseases
(NCDs; ie, cardiovascular disease, chronic kidney disease, dia-
betes/metabolic disorders, and neurological disease) among a
5-country transatlantic network including Austria, Canada,
Cyprus, Spain, and Sweden. A multistep process was applied.
Step 1 (Identification of Gender-related Variables): each part-
ner provided the data dictionary of the database/cohort they
included in the GOING-FWD application. Based on the gender
framework of the Women Health Research Network (ie, gender
identity, gender role, gender relations and institutionalized gen-
der), and available literature for certain disease, an optimal
“wish list” of gender-related variables/factors was created. Step
2 (Definition of Outcomes): each of the cohort data diction-
aries were screened for outcomes of interest outlined in the
GOING FWD proposal, including clinical/survival and patient
reported outcomes. Step 3 (Building of Feasible Final List):
A cross-validation between gender-related variables and out-
comes variables available per database was performed. In case
of disagreement or discordant definitions of variables, a more
inclusive approach was pursued for both gender-related vari-
ables and outcomes. Each variable was discussed at the inau-
gural meeting (April 2019) of the GOING-FWD investigators
and consensus was reached on a final list of “gender-related”
and “outcome variables.” Each country partner used the lists to
apply to their respective research ethics boards. Step 4 (Defi-
nition of Data Structure): Depending on the type of database,
each partner then provided the data management structure and
the analysis plan based on the following options: (1) data are
not transferable even if anonymized—study-specific data anal-
yses will be done locally and followed by a meta-analysis
combining the study-level estimate (2) analyses will be done
centrally, but the individual-level participant data will remain
on local servers. (3) Data transferable: data will be pooled and
analyzed at a central location. Step 5 (Retrospective Data Har-
monization): Finally, a list of harmonized variables will be
created using the Maelstrom Research guidelines for rigorous
retrospective data harmonization and merging when possible.
In summary: Personalized medicine approach is increas-
ingly appreciated in clinical research, where the need for anal-
ysis of already collected data requires a proper definition of
variables and measures included. Therefore, when including
gender, the existing lack of a standardized gender measure
poses challenges which might be mitigated via application of
a systematic multistep approach currently suggested and cur-
rently tested by our multidisciplinary team. Understanding of
how sex and gender-related factors impact NCDs will help to
improve clinical- and patient-related outcomes with potential
to tailor future interventions with a sex- and gender-specific
approach.
Described Differences Between Men and
Women Regarding Antiretroviral Drugs for
Treatment of HIV
von Euler M1,3, Jaran Eriksen1, Karlsson-Lind L4 and
Schenck-Gustafsson K3,5
1Department of Clinical Pharmacology, Karolinska University
Hospital, Stockholm, Sweden
2Department of Medicine, Division of Clinical Pharmacology,
Karolinska Institutet, Stockholm, Sweden
3Department of Medicine, Centre for Gender Medicine, Karolinska
Institutet
4Department of Digital Health and Care, The Health and Medical
Care Administration, Region Stockholm, Stockholm, Sweden
5Department of Medicine, Cardiac Unit, Karolinska University
Hospital, Stockholm, Sweden
In the data base Janusmed Sex and Gender (janusinfo.se/genus/
in-english) evidence-based medical knowledge on sex and gen-
der aspects on drug treatment has been gathered into a search-
able tool. In 25% of the included medical drugs included in the
data base, information on sex and/or gender differences are
lacking. Antiretroviral drugs for treatment of HIV is one of the
therapeutic areas covered. These drugs are often used over a
long period of time and in different phases of the reproductive
life of both men and women. We hypothesized that sex/gender
differences were studied and reported more compared to other
drug classes. The following search string was used in PubMed:
(“Sex Factors”[Mesh] OR “Sex Characteristics”[Mesh] OR
sex[Title] OR gender[Title] OR “sex difference*” OR “gender
difference*” OR “based on sex” OR ”based on gender”) AND
«antiretroviral substance» In all, 18 drugs were included. No
information on sex or gender differences were found for one
(5.5%) of the substances (cobicistat). For 13/18 (72%) of the
included drugs the identified literature indicated no clinically
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relevant sex differences while in 4 (22.5%) sex differences
were identified. The most important being nevirapine where
the increased risk of hepatotoxicity and skin reactions need
to be considered particularly in women/girl as the risk is higher
in female compared to male patients. For several of the nucleo-
side analogues the risk of adverse reactions such as lactic
acidosis and severe hepatomegaly with steatosis are more com-
mon in women. More data on sex differences are published
regarding antiretroviral drugs for treatment of HIV. The differ-
ence mainly concerns an increased risk of some specific
adverse reactions more common in women.
Utilization of Antiepileptic Drugs in Men and
Women with Stroke
Linnéa Karlsson Lind1 and Mia von Euler2
1Department of Digital Health and Care, Health and Medical Care
Administration, Region Stockholm, Sweden
2Department of Clinical Pharmacology, Karolinska University
Hospital, Stockholm, Sweden
Stroke is a common cause of epileptic seizures in adults. How-
ever, treatment of patients with poststroke epilepsy is challen-
ging since high-level evidence-based guidelines are lacking.
Whether or not antiepileptic drugs (AEDs) should be used is
therefore controversial. The aim of the present study was to
investigate which AEDs are used in men and women with
stroke in a nationwide population. All adults (>18 years) with
a first dispensation of an AED (ATC-code N03A) in 2007 to
2014 were identified in the Swedish Prescribed Drug Register
and cross-sectional data on history of a diagnosis of ischemic or
hemorrhagic stroke in the five years preceding the first AED
dispensation were collected from the National Patient Register.
Patients with an AED dispensation preceding their stroke diag-
nosis were excluded. We calculated proportions of patients
initiated on each AED, stratified by patient’s sex. A total of
11 107 first dispensations of AEDs in 10 645 patients (52%
women) were included. First AED after ischemic stroke was
gabapentin in both men and women (32% respectively). First
AED after hemorrhagic stroke was gabapentin in women
(25%), and carbamazepine in men (31%). After excluding
AEDs frequently used for other indications (gabapentin, preg-
abalin), carbamazepine was most common, followed by leve-
tiracetam, in both men and women and in both stroke subtypes.
During the study period, the proportion of patients initiated on
gabapentin and levetiracetam increased while the proportion
initiated on carbamazepine and pregabalin decreased. The use
of gabapentin is in agreement with guidelines for treatment of
focal seizures in the elderly. However, the high use of gaba-
pentin, as well as pregabalin, could also reflect high prevalence
of neuropathic pain, particularly in women. Carbamazepine has
traditionally been recommended for use in adults with focal
seizures, but its tolerability has been discussed.
The Diagnosis of Osteoporosis in Statin-
Treated Women and Men is Dose-Dependent
Leutner Michael1, Matzhold Caspar2,3, Bellach Luise1,
Deischinger Carola1, Harreiter Jürgen1, Thurner
Stefan2,3,4,5, Klimek Peter2,3, and Kautzky-Willer
Alexandra1
1Department of Internal Medicine III, Clinical Division of
Endocrinology and Metabolism, Unit of Gender Medicine, Medical
University of Vienna, Vienna, Austria
2Section for Science of Complex Systems, CeMSIIS, Medical
University of Vienna, Spitalgasse, Austria
3Complexity Science Hub Vienna, Josefstädter Straße 39, 1080
Vienna, Austria
4Santa Fe Institute, 1399 Hyde Park Road, Santa Fe, NM 85701,
USA
5IIASA, Schlossplatz 1, A-2361 Laxenburg, Austria
Objective: Postmenopausal women are at exaggerated risk of
developing osteoporosis. Statins lower cholesterol levels by
inhibiting the HMG-CoA-reductase inhibition, which is the
main substrate for the synthesis of sex hormones. Conse-
quently, this study was set out to investigate the sex-specific
relationship of different kinds and dosages of statins with
osteoporosis. Methods: Medical claims data of all Austrians
from 2006 to 2007 was used to identify all patients treated with
statins to compute their daily defined dose averages of six
different types of statins. We applied multiple logistic regres-
sion to analyse the dose-dependent risks of being diagnosed
with osteoporosis for each statin individually. Results: We
identified 353 502 statin-treated patients (175 506 males, 177
996 females) out of which 11 701 patients (1765 males, 9936
females) were diagnosed with osteoporosis. The control group
(no statin exposure) consisted of 7 543 947 patients (3 527 066
males, 4 016 881 females), including 68 699 patients (10 410
males, 58 289 females) diagnosed with osteoporosis. Within
the whole study population, our results show that women are at
a higher risk of being diagnosed with osteoporosis when com-
pared to men (odds ratio [OR]: 5.08, 95% confidence interval
[CI]:4.98-5.18, P < .01). In a sex-specific analysis, only a low
dose simvastatin (10 mg) treatment was related to an under-
representation of diagnosed osteoporosis in males and a low
dose lovastatin (10 mg), fluvastatin (>10-20 mg), pravastatin
(10 mg), and simvastatin (10 mg) treatment in females. In
both females and males, the increase in the dosage of simvas-
tatin (>40 mg) and atorvastatin (>10 mg) was related to a
higher occurrence of a diagnosed osteoporosis. However,
females with a rosuvastatin dosage of >20 to 40 mg had an
exaggerated risk of being diagnosed with osteoporosis (OR:
3.01, CI: 1.73-5.21, P < .01) when compared to controls. Con-
clusion: Our results show that the diagnosis of osteoporosis in
statin-treated patients is dose-dependent in both, women and
men. Thus, osteoporosis is underrepresented in low-dose and
overrepresented in high-dose statin treatment.
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Differences in Discontinuation of Statin
Treatment in Women and Men With
Advanced Cancer Disease
Helena Bergström1, Elsa Brånvall2,3, Maria Helde-
Frankling1,2, and Linda Björkhem-Bergman1,2
1Department of Neurobiology, Care Sciences and Society (NVS),
Division of Clinical Geriatrics, Karolinska Institutet, Blickagången,
Huddinge, Sweden
2ASIH Stockholm Södra, Palliative Home Care and Hospice Ward,
Bergtallsvägen, Älvsjö, Sweden
3Division of Clinical Epidemiology, Department of Medicine Solna,
Karolinska Institutet, Stockholm, Sweden
Statins are often discontinued in patients with advanced cancer
since the net effect of treatment is considered negative. How-
ever, guidelines concerning discontinuation of statin treatment
are lacking. The aim of this study was to investigate any dif-
ferences in time of discontinuation of statin treatment between
men and women with advanced cancer disease. Medical
records from 195 deceased patients with palliative cancer from
a previous study cohort were reviewed. Patients treated with
statins 2 years before death were identified as “statin users.”
The time of discontinuation of statin therapy was identified and
correlated to time of death. Only patients with incurable cancer
disease at time of statin discontinuation were included in the
analysis. Fifty-four patients were identified as statin users, 29
women and 25 men. The average time span between disconti-
nuation of statin treatment and time of death was significantly
longer in women than in men, 10 months compared to 4 months
(P < .01), with a range of 1 to 24 months among women and 1
to 12 months for men. All patients died due to cancer disease.
More men than women had a history of stroke or cardiac infarc-
tion (P ¼ .02). There were no differences in age, socioeco-
nomic factors, or survival time from study inclusion between
men and women. There was no difference in self-assessed
quality of life (QoL) between statin users who had discontinued
statin treatment and those who are still on treatment. Men
generally assessed their QoL lower than women in this study
(P¼ 0.03). Statin treatment was discontinued earlier in women
than in men with advanced cancer disease, and discontinuation
was not associated with any negative effects. However, the
results need to be confirmed in larger studies before any firm
conclusions can be drawn. Future studies will elucidate if early
statin discontinuation is safe in both men and women with
advanced cancer disease.
Gender Violence: A Study of Awareness
Implementation at the University Hospital of
Ferrara, Italy
Rosaria Cappadona1, Roberta Capucci1, Camilla
Paganelli1, Monica Rizzati1, Fabio Fabbian1, Roberto
Manfredini1, Greco P1, Maria Aurora Rodriguez
Borrego2, and Pablo Jesus Lopez Soto2
1University of Ferrara, faculty of Medicine, Pharmacy and Prevention,
Ferrara, Italy
2Department of Nursing, University of Cordoba, Maimonides
Institute of Biomedical Research of Cordoba (IMIBIC), Cordoba,
Spain
Gender violence represents international public health burden.
However, there is limited knowledge of epidemiological data in
Italy. Thus, we decided to perform a study with the following
aims: (1) collecting epidemiological data aimed at assessing
implementation of the guideline protocol “Care and treatment
for women victims of gender violence” developed by the Uni-
versity Hospital of Ferrara (year 2013) according to the Istanbul
Convention on Violence against Women, (2) developing an inte-
grated approach between health-care professionals and police
officers in case of gender violence. Data were extracted from
the reports of women referring to the emergency room (ER) for
gender violence, University Hospital of Ferrara, Italy, years
2008 to 2016. The final total sample included 1955 women,
average: 217 cases/year. Women were predominantly Italian,
aged between 26 and 60 years. In details, 94% of cases involved
assault and battery as gender violence; 3.1% involved sexual
assault, 2.9% had no precise data, since women omitted any
description of the violence. In 2.6% of cases, women victims
of gender violence were pregnant. The abuser was more often
the victim’s partner, followed by former-partner/relative, and
identity remained unknown in 1.7% of cases. Repeated violence
occurred in 318 (16.3%) cases. The introduction of the above
quoted Guideline Protocol led to improvements in the regional
network of services for women victims of gender violence.
Furthermore, the training for health professionals improved
awareness and quality of delivered care. The ER clinical notes
were more accurate in reporting details about type and frequency
of violence episodes, allowing considerable improvement in the
clinical practice. Finally, in cases of gender violence, the number
of yellow tags, according to the triage codifying system,
increased, and information exchange between hospital health-
care professionals and police officers significantly improved.
Gender Related Violence: An Observational
Study
Tiziana Ciarambino2, Ilenzia Sanzo2, Ilaria Boccagna2,
Carla Iuliano1, Raffaella Ferrucci1, Filomena Maietta1,
Giuseppina Quintili1, Laura Leoncini3, Cecilia Politi1 and
Mauro Giordano1
1Health Direction, Hospital of Marcianise, ASL Caserta, Italy
2Women’s Space Association, Project REVIVAL (Right Environment
to protect women victims of violence at each level)
3Department Internal Medicine, Hospital of F. Veneziale, ASREM,
Italy
Introduction: The Istanbul Convention (2011) is the first bind-
ing instrument on preventing and combating violence against
women and domestic violence. Objective: It is to put in place
the actions in favor of women victims of male violence through
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a multifactorial approach and followed actually. Materials and
Methods: We enrolled 28 women with an average age of 52 +
4 years, who arrived at the Sessa Aurunca ASL Caserta, Italy,
in the period 2017 to 2018 for gender-related violence.
Results: The study population consisted of 25 women of Italian
origin and 3 of non-EU origin. Of these, 70% were married,
10% separated, 10% unmarried, and 10% widowed. Over 50%
of cases were victims of family violence. In over 50% of cases,
the perpetrator of violence was a husband or a former husband.
In particular, in 20% of cases, it was psychological violence, in
30% of cases of stalking, in 25% of cases of relational conflicts,
in 25% of cases legal problems. The interventions carried out
by the multidisciplinary team contributed to send 4% of cases
in a hospitalization, 4% of cases in shelters, and 92% of cases to
support victims of violence with specialist advice from inter-
nists, gynecologists, lawyer, and psychologists. Among these
65% were integrated into the world of work. All were sup-
ported psychologically and legally. The perpetrators of the
violence in 95% of the cases were removed from the home and
in 5% of the cases were arrested. Conclusion: It is therefore
essential to prevent the phenomenon of violence against
women using as primary tools information and awareness of
the community, strengthening the awareness and culture of
men and young people.
Connecting Midwives and Violence
Prevention Institutions—One Step in
Fighting Violence Against Women
Siller Heid1, Pittl Manuel2, Zenzmaier Christoph2,
Perkhofer Susanne2, Hochleitner Margarethe3, and
König-Bachmann Martina4
1Medical University of Innsbruck, Gender Medicine Unit, Innsbruck,
Austria
2Health University of Applied Sciences Tyrol, Innsbruck, Austria
3Gender Medicine Unit, Medical University of Innsbruck, Innsbruck,
Austria
4Department for midwifery, Health University of Applied Sciences
Tyrol, Innsbruck, Austria
Violence against women (VAW) is an ongoing concern in
health care. It encompasses domestic violence, but also other
types of violence only or disproportionally often affecting
women. Constant improvements are made to provide best pos-
sible support for women affected by VAW. Reducing barriers
in accessing violence prevention institutions and knowledge
about referral possibilities are important aspects when caring for
women affected by VAW. Three qualitative studies with 15
midwives, 21 midwifery students, and 11 representatives of vio-
lence prevention institutions, respectively, were conducted by
using either interviews or focus groups. These studies were con-
ducted in one part of Austria. Findings showed that there is still a
disconnection between these professionals in particular regard-
ing pregnant women. It was also found that midwives who had
received training in VAW and younger midwives and midwifery
students were more open to including VAW. Continuous care
was an important concern in interviews. This is also reflected in
the midwives’ role as guided guides. Violence prevention insti-
tutions reported that only very few pregnant women contacted
them. By combing the findings of all 3 studies, a disconnection
between all actors in the field of VAW appeared. Therefore, the
so-called meet and greets were developed and will be implemen-
ted in autumn/winter 2019. Thereby, midwives, professionals
(psychologist and psychotherapists), and representatives of vio-
lence prevention institutions will constitute a support network
for each other in fighting VAW. Setting up small networks in
several areas in Tyrol, Austria, is expected to reduce barriers and
increase access to support.
Gender Differences in Dentists’ Working
Practices and Job Satisfaction in Germany
Christiane Gleissner1, Nina Düchting1, Ulrike Uhlmann1,
and James Deschner1
1Department of Periodontology and Restorative Dentistry, University
Medical Centre, Johannes Gutenberg-University, Mainz, Germany
There has been a steady increase in the proportion of women
among dentists over the last 30 years. Female dentists have
been shown to work fewer hours per week and take longer
career breaks, raising concerns about maintaining
community-based dental care in the future. This pilot study
aimed to compare the working practices, family life, and job
satisfaction of male and female dentists. The study was a web-
based 50-item survey on sociodemographic data, working sit-
uation, work–life balance, family life, and income. Of this,
1500 dentists were contacted by mail using the database of the
local state chamber of dentists. One hundred eighty-nine ques-
tionnaires (93 M, 96 F; 44.5 + 12.0 years) were eligible for
analysis which included w2 and Mann-Whitney U test,
Spearman-correlation, and linear-regression analysis. Of this,
71.0% of the men and 37.9% of the women owned their own
practice, 4.3% of the men and 46.3% of the women worked as
employees. The mean number of working hours per week was
51.1 for males and 42.1 for females; 26.7% of the men and
49.4% of the women were childless. The mean number of
children was 1.2; males had more children than females; 66%
of the women’s partners worked full time, but only 24% of the
men’s; 30% of the women (men: 7.5%) reported that their
income had decreased after a career break for child rearing.
Women’s average income before taxes was significantly lower
than men’s. Mean job satisfaction for males was 12.6 and 11.9
for females (P< .05). Job satisfaction of males was determined
by “burden” and “income,” whereas “number of persons living
in the household” determined job satisfaction of females. Male
and female dentists differ in their working and family situa-
tions; this affects their job satisfaction. Such differences should
be addressed in order to improve and maintain community-
based dental care.
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Masculinity Is Associated With Male Medical
Students’ Discomfort With Regard to Asking
Patients About Sexual Health Issues
Nikola Komlenac, PhD1, and Margarethe Hochleitner,
MD1
1Gender Medicine Unit, Medical University of Innsbruck, Innsbruck,
Austria
Factors contributing to physicians’ or medical students’ dis-
comfort with addressing patients’ sexual health have rarely
been addressed. The current study analyzed whether masculine
gender role conflict (GRC), next to the often cited factor of knowl-
edge, was associated with male students’ comfort with regard to
asking future patients about sexual health issues. A cross-
sectional questionnaire study was conducted at an Austrian med-
ical university with 164 male medical students (mean age¼ 24.4
years, SD ¼ 2.4). Students’ self-perceived knowledge of sexual
health, how prepared they felt about this topic and their comfort
with regard to asking future patients about sexual health issues
were assessed. The Gender Role Conflict Scale—Short Form was
used to assess GRC. Male students reported being more comfor-
table about asking male patient groups than female patient groups
(Ps< .040). Male students who indicated difficulty with expres-
sing affection towards men were more likely to report being
uncomfortable about asking patients overall, male patient groups,
and elderly female patients (ORs> 1.6, Ps< .020). Furthermore,
male students who felt distress when showing emotions were
more likely to report being uncomfortable about asking adult
female patients (OR¼ 1.6, P¼ .012). Knowledge was positively
associated with comfort about asking patients overall and female
patient groups (ORs > 2.3, Ps < .037). The current study shows
that it is not enough to convey facts and skills in order to increase
male medical students’ comfort in dealing with patients’ sexual
health issues. Male students should be made aware of gender role
norms that influence such conversations, and the discussion of
strategies for overcoming the barriers set by these norms should
be part of sexuality education.
Mistreatment and Incivility at the Medical
University of Innsbruck—Focusing on Muslim
Students
Gloria Tauber1, Heidi Siller1, Silvia Exenberger2, and
Margarethe Hochleitner1
1Medical University of Innsbruck, Gender Medicine Unit, Innsbruck,
Austria
2Medical University of Innsbruck, Medical Psychology, Innsbruck,
Austria
The study focuses on mistreatment and incivility in medical
students at the Medical University of Innsbruck (MUI). Mis-
treatment and incivility includes subtle sexist and racist
remarks and lack of regard and was found to affect more often
marginalized and minority groups (eg, migrants, women,
sexual minorities, etc). In Austria, Europe, 8% of the popula-
tion is estimated to be Muslim. The objectives of this study
were to investigate whether women and minority groups expe-
rience more incivility and might compensate this experience
with more persistence and ambition regarding their career com-
pared to men and majority students. In a pilot study, Muslim
medical students (n ¼ 35) filled in a questionnaire on resili-
ence, incivility, and career orientation in the workplace. A non-
Muslim control group of 42 medical students was recruited to
compare findings on resilience, incivility, and career orienta-
tion. Findings show that Muslim students experience signifi-
cantly more often incivility than the control group, but no
gender differences were found regarding incivility. Muslim
students also reported a significantly greater orientation toward
careers, which was not connected to incivility. Contrary to our
expectations, women at the MUI do not report incivility more
often than do men, but Muslim students report more often
incivility than non-Muslim students. This study elucidates the
need to detect mechanisms of which aspects are intersecting
and experienced as uncivil and mistreating and how this influ-
ences the career orientation. Long-term studies to see the
impact of incivility and careers in minority and majority groups
would be interesting and important.
Sex and Gender Specific Aspects in the
Development of Post Stroke Depression and
ITS Effects on Neuro-Rehabilitation Success
Jürgen Harreiter1, Ulrich Schneeweiss1, Wolfhard Klein2,
Hermann Moser2, and Alexandra Kautzky-Willer1,3
1Gender Medicine Unit, Division for Endocrinology and Metabolism,
Department of Medicine III, Medical University Vienna, Vienna,
Austria
2Neurological Therapy Center Gmundnerberg, VAMED, Austria
3Gender Medicine Institute, Gars am Kamp, Austria
Worldwide stroke is one of the most common causes of death.
Survivors are often dependent on assistance in their daily life
activities. Beside the personal fates, the resulting economic bur-
den to health-care systems is high. Effective rehabilitation pro-
grams increase the quality of life and reduce the economic burden
by lowering the costs for continuing care. Considering the
individual needs of every patient is a basic requirement for a
successful rehabilitation process. The examination of sex- and
gender-specific differences in rehabilitation shall contribute to
the further improvement in the rehabilitation processes. This ret-
rospective study included 1593 stroke patients who underwent
neurorehabilitation from 2010 to 2015. The change in the Barthel
Index during rehabilitation was chosen as marker for the rehabi-
litation effect. A linear regression model was used to examine the
influence of sex and multiple confounders on the rehabilitation
effect as well as on the occurrence of depression and pain. The age
was comparable between sexes (male: 68.2 + 11.9 vs female:
69.3 + 13.6 years). At admission, women had lower Barthel
Index (m¼ 84.7+ 23.8; f¼ 79.9+ 25.9; P< .001). Parameters
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affecting the change of Barthel index significantly were age, time
since stroke and Barthel Index on admission. Pain level on admis-
sion, sex, and depression was not associated with the rehabilita-
tion effect. However, female sex, high pain levels, and low
Barthel Index on admission were significantly associated with
depression. Women suffered more frequently (male ¼ 226/
34.6%; female¼ 205/44.3%; P< .001) from pain and addition-
ally were indicating higher pain levels (male¼ 1.6+ 2.4; female
¼ 2.0 + 2.6; P ¼ .002), which was associated with depression.
Men and women have beneficial effects of neurorehabilitation,
but factors associated with female sex (low Barthel Index on
admission, pain) impact the rehabilitation effect in a negative
way. Women are at higher risk for depression, as well as indicate
pain more frequently and in higher intensity.
Malnutrition Influence and Outcome in
Cardiovascular Rehabilitation: Pilot Study
A. Guttmann1, S. M. Hörsit-Kollmann2, C. Prenner2, A.
Deutsch2, M. Kristoferitsch2, A. Krautsack2, E. Wappl2,
W. Kullich3, B. Thauerer3, and J. Strametz-Juranek2
1Medical University Graz, Graz, Austria
2Sonderkrankenanstalt—Rehabilitationszentrum Bad
Tatzmannsdorf, Austria
3Ludwig Boltzmann Institut fu€r Arthritis und Rehabilitation,
Department fu€r Rehabilitation Saalfelden, Austria
Cardiovascular diseases are the leading cause of death worldwide.
Modern medicine increases the number of elderly and old patients
in stationary rehabilitation. Malnutrition, weight loss, sarcopenia,
and low protein levels are associated frequent falls, which, in
combination with high age, count as independent risk factor for
cardiovascular diseases. The aim of this pilot study was to eval-
uate the efficiency of cardiovascular rehabilitation treatments in
elderly and old patients and the influence of a purposeful screen-
ing and treatment for malnutrition on the outcome. All patients
underwent AKE-screening, blood sampling, BIA, SPPB, and the
6MWT at start and at the end. To calculate the total energy
demand of our patients, we used our gender-specific energy cal-
culator. In stationary rehabilitation on ward a total of 31 people
(19 female, 12 male) took part in the study. Thirteen patients had a
risk of malnutrition, 18 already were malnutritioned. Patients with
a risk of malnutrition were randomized 2 groups. The test group
and all malnutritioned patients got daily a nutritional supplement
with high protein levels. All participants of both study groups
showed improvements in their physical ability like the 6MWT
(A: 233.11 m + 81 m to 294.6 m + 76.7 m; P ¼ .002) and the
SPPB (A: 6.25 + 2.26 to 10.9 + 1.66; P ¼ .002). Results of
6MWT (211.7 m + 56.9 m to 280 m + 54.7 m; P ¼ .001) and
SPPB (5.62 + 1.99 to 10.57 + 1.9; P ¼ .015) in the test group
increased significantly compared to the control group. Malnutri-
tion is a primary issue in rehabilitation. Elderly and old people
benefit from rehabilitation. Malnutrition significantly affects
treatment outcome and aims of cardiovascular rehabilitation. Tar-
geted interdisciplinary treatment of malnutrition goes along with
a significant improvement of muscle strength, walking speed and
balance, important for fall prophylaxis, and cardiovascular
outcome.
Sex Related Differences in Major Depression
in an Austrian Sample: Evidence for the
Necessity of Gender Specific Treatment
Karin Schwalsberger1,2, Bernd Reininghaus1,2, Nina
Dalkner2, Laura Antonia Lehner1, Alexandra Rieger2, and
Eva Reininghaus2
1Therapiezentrum Justuspark, Bad Hall, Austria
2Department of Psychiatry and Psychotherapeutic Medicine, Medical
University of Graz, Graz, Austria
The preponderance of depression in women appears to be a
universal and substantial finding. A woman is about 1.7 times
more likely to have unipolar affective disorder than a man. Aim
of this study was to investigate sex sex-related differences in
unipolar affective disorders. Differences between men and
women regarding sociodemographic variables, symptoms,
medical treatment, and comorbidities were examined and mul-
tiple explanations for the differences were discussed. The data
of 695 patients of a rehabilitation clinic in Austria were ana-
lyzed. Of the 695 patients, 465 were admitted with the diag-
nosis of major depression and therefore were included in the
study. Different (neuro-) biological and psychological para-
meters were compared at the beginning and at the end of a 6-
week rehabilitation period between women and men. Men and
women showed no differences in depressive symptom severity;
however, anxiety was significantly higher in women. Male
individuals showed a significantly higher body mass index than
women, and in line with that, cardiovascular diseases were
more frequent in men. Women on the contrary displayed a
significantly higher rate of thyroid dysfunctions. There was
no significant difference in the number of psychotropic sub-
stances taken. Not only are women almost twice as often
affected by depression than men, the chronic disease affects
the male and female body and mind in a different way. Men
have a stronger vulnerability of the cardiovascular system,
women seem to have a hormonal imbalance (thyroid gland),
which could explain the higher rate in anxiety, since thyroid
dysfunction and anxiety have been found to be highly corre-
lated. These gender-specific differences need to be taken in to
account in the treatment of major depression to improve the
psychological and physiological well been of the patients.
Gender Gap in Diagnosis of Depression More
Prevalent in Type 2 Diabetes Mellitus
Patients than Non-Diabetics in Austria
Deischinger Carola1, Dervic Elma2,3, Kosi-Trebotic Lana1,
Kautzky Alexander4, Klimek Peter2,3, and Kautzky-Willer
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Introduction: In addition to type 2 diabetes patients being
more prone to depression, gender differences such as a higher
probability of females being diagnosed with depression have
been established in the past. The exact causes are still unclear,
but biological factors, hormonal differences, and gender stereo-
types are likely contributing to males being under- and women
overdiagnosed. For instance, cardiovascular diseases (CVD) are
still commonly missed or mistaken for mental health problems in
women despite the 2 to 3 times elevated risk for CVD in female
type 2 diabetics. Methods: An analysis of a medical claims
database of the Austrian Ministry of Health containing the entire
Austrian population (N ¼ 8 996 916) from 2003 until 2014 was
conducted. Of these, 213 986 patients with diabetes mellitus type
2 were extracted and compared to nondiabetic controls. Results:
In Austria, females with type 2 diabetes mellitus have 2.14-fold
increased odds to be diagnosed with depression compared to
nondiabetic females (OR ¼ 2.14, 95% CI ¼ 2.09-2.19) whereas
diabetic males had significantly lower increased odds (P <
1013) with 1.88-fold increased risks compared to nondiabetic
males (OR ¼ 1.88, 95% CI ¼ 1.84-1.94). Conclusion: In com-
parison to the general population, the gender gap in the diagnosis
of depression is greater in the diabetes cohort. Besides biological
factors, this significant sex difference might stem from female
diabetics being even more likely to be overdiagnosed with
depression and underdiagnosed in other areas such as cardiovas-
cular diseases when compared with nondiabetic women.
Lack of Gender-Specific Knowledge on How
Psychological Factors Contribute to Pre-
Hospital Delay After Myocardial Infarction
Sophie H. Bots1, Karlijn B. Rombouts1, Hajo W.
Boersma1, Mark C. H. de Groot2, Saskia Haitjema2, and
Hester M. den Ruijter1
1Laboratory of Experimental Cardiology, University Medical Center
Utrecht, Utrecht University, Utrecht, the Netherlands
2Laboratory of Clinical Chemistry and Haematology, University
Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
Women suffering from myocardial infarction (MI) wait longer
to contact medical services than men, while quick treatment is
crucial to reduce permanent cardiac damage. Traditional gen-
der roles may affect health-care-seeking behaviour by defining
gender-specific socially acceptable behavior. Faced with the
same medical emergency, women and men may thus act
differently according to their internalized gender role. How-
ever, this has not yet been fully elucidated. We performed a
systematic review of the literature to evaluate whether the
effects of psychological factors on prehospital delay differ
between women and men and validated our findings in a pilot
study. Our search of PubMed and Embase returned 3634
unique articles, of which 92 were eligible for full-text screening
and 11 (published between 1998 and 2018) were included.
These articles included 2624 patients (30% women) and cov-
ered the psychological factors denial (n ¼ 3), anxiety (n ¼ 6),
embarrassment (n ¼ 3), and fear (n ¼ 6), with some articles
covering multiple factors. Half of the evaluations (9/18) only
reported factor prevalence by gender. Some results suggested
that denial increased delay (n ¼ 1, 161/533 women), anxiety
decreased delay (n ¼ 2, 120/328 women), and embarrassment
and fear had no effect on delay (n ¼ 1, 96/194 women) in both
genders. Others showed that anxiety decreased delay only in
men (n ¼ 1, 36/98 women) or only in women (n ¼ 1, 162/619
women), while embarrassment and fear increased delay only in
men (n¼ 1, 24/134 women). We screened the electronic health
record (EHR) of 100 men and 104 women admitted to the
University Medical Center Utrecht with an ST-elevation MI.
With the exception of embarrassment as delay reason for one
woman, psychological factors were not mentioned in the EHR.
Psychological factors seem to affect prehospital delay after an
MI similarly in both genders, but limited data question the
validity. Large standardized studies with proportionate num-
bers of women are needed to draw final conclusions.
Real Men Don’t Cry—Gender Differences in
Coping With Cancer
Anahita Paula Rassoulian1
1Medical University of Vienna, Vienna, Austria
“Real men don’t cry,” “talking about fear and sorrows are only
for women”—do these and similar prejudices still exist today?
Men and women handle life challenges differently. They differ
in the way they perceive challenges, communicate, in their
social relationships, and in the way, they deal with major
challenges, such as cancer and disease. Despite medical prog-
ress cancer is still a life-threatening disease and throws a
person’s views on life into disarray. Studies indicate that
depression and anxiety are highly prevalent in patients with
cancer and that gender plays an important role in the way
patients cope and communicate with their oncologist, family,
and friends. By providing patient-centered care, we would
benefit from acknowledging and talking about gender issues
and gender differences concerning how male and female
patients cope with their cancer disease—what it means to
them, how they deal with it in their daily life, and how it
influences their personal life and relationships. Interviews with
male and female patients with cancer show a clear tendency
toward gender differences in coping with cancer. The results
do not support any stereotypes of male and female behavior or
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social structures—but it mirrors the real life of human beings!
And yes, real men do cry!
Self-Harm and Suicidality—Are There
Gender Specific Causes?
Hannah Münch1, Manuel Sprung1, Lore Streibl1, Elmar
Kaiser1, and Friedrich Riffer1
1Psychosomatisches Zentrum Waldviertel, Universitätsklinik für
Psychosomatische Medizin der Karl Landsteiner Privatuniversität,
Eggenburg, Österreich, Austria(all Authors)
Objective: Self-harming and suicidal behavior are common
in individuals with psychiatric disorders. The objective of this
study is to examine whether there are gender-specific differ-
ences in risk factors for self-harming and suicidal behavior.
Methods: We analyzed self-report data of N ¼ 677 inpatients
(37.4% male) from a psychosomatic clinic in Austria using
logistic regression analyses. Self-harm and suicide attempts
were assessed by one question with a dichotomous answer
format (yes/no). Assumed predictors were childhood trauma,
anxiety, depression, type of mental disorder, family situation,
education level, and general life satisfaction. Results: Sepa-
rate analyses for each gender revealed an increased risk for
self-harm and/or suicide attempt in females with a history of
physical abuse during childhood. For males with history of
emotional abuse or physical neglect during childhood or who
are currently living alone the risk was also increased. Discus-
sion: These results suggest a critical role of childhood trauma
for self-harm and/or suicide attempts in adulthood, with
gender-specific difference regarding the type of childhood
trauma.
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